Introduction {#s1}
============

The nucleolus, a membrane-less organelle, is the site of ribosome biogenesis and a cellular stress sensor ([@bib7]). Nucleoli contain three substructures: the fibrillar centers (FCs) and dense fibrillar component (DFC) are engulfed in the granular component (GC) ([@bib7]), which exhibits ATP-dependent liquid-like features ([@bib8]). Ribosomal RNA (rRNA) genes are transcribed between the FC and DFC, and rRNAs are processed while migrating into the GC, wherein they assemble with ribosomal proteins to form pre-ribosomal particles ([@bib7]). Nucleophosmin (NPM1, also known as B23), a highly abundant marker of the GC, functions as a nucleolar chaperone and plays a role in cellular stress responses ([@bib15]). While appreciated ([@bib8]; [@bib11]; [@bib51]; [@bib64]), the molecular basis of the GC's fluidity is unknown.

While *Npm1* loss is embryonic lethal in mice, mouse fibroblasts derived from *Npm1*^-/-^/*Trp53*^-/-^ embryos readily proliferate in culture ([@bib14]), indicating that NPM1 is dispensible for ribosome biogenesis. However, NPM1 is known to influence ribosome biogenesis, genome stability and tumor suppression ([@bib45]) and to participate in responses to cellular stresses, including DNA damage ([@bib42]), chemotoxicity ([@bib10]; [@bib68]), and oxidative stress ([@bib54]). Furthermore, NPM1 depletion is associated with disruption of nucleolar structure ([@bib30]). We propose that NPM1 participates in the organization of the liquid-like structure of the GC and consequently may actively participate in stress signal integration and transmission, thereby explaining its known roles in ribosome biogenesis, tumor suppression and other processes ([@bib45]). Accordingly, NPM1 interacts with a vast array of partners (<http://thebiogrid.org/110929/summary/homo-sapiens/npm1.html>), many involved in ribosome biogenesis, and controls the nucleolar localization of ribosomal ([@bib46]; [@bib56]), viral ([@bib17]; [@bib20]), and certain tumor suppressor proteins ([@bib6]), many of which engage the N-terminal oligomerization domain (OD) of NPM1 ([Figure 1a](#fig1){ref-type="fig"}) via arginine-rich short linear motifs (R-motifs) ([@bib50]). Furthermore, NPM1 binds nucleic acids (e.g., rRNA and DNA) through its C-terminal domain (nucleic acid binding domain, NBD) ([@bib63]). We seek to understand the molecular mechanisms of NPM1's multifarious functional interactions. Here, we show that NPM1 undergoes liquid-liquid phase separation in the presence of two classes of nucleolar macromolecules: proteins and RNA. Using a multidisciplinary strategy, we identify the structural features that mediate NPM1 phase separation and its nucleoar localization. These results provide a novel perspective on the mechanisms involved in the formation of the liquid-like structure of the nucleolus and in the nucleolar localization of biological macromolecules.10.7554/eLife.13571.003Figure 1.Multivalency of acidic tracts within NPM1 and R-motifs within nucleolar substrates mediates liquid-liquid phase separation.(**a**) Composite model of NPM1 structure; the oligomerization domain (OD, green, PDB ID 4N8M), containing the A1 acidic tract (red), is connected via a disordered region (IDR, grey), containing two additional acidic tracts (A2 & A3, red), to the C-terminal nucleic acid binding domain (NBD, blue, PDB ID 2VXD); (**b**) Phase separation diagrams for mixtures of N130 and four R-motif containing peptides (bottom dot graphs); phase separation was assessed by the formation of liquid-like droplets detected using light microscopy (grey dot, clear solution observed; green dot, liquid-like droplets observed). Representative examples of liquid-like droplets formed between 50 μM N130 and the lowest peptide concentration associated with phase separation, visualized by DIC (top panel) and Alexa Fluor488 emission of labeled N130 (bottom panel) are illustrated. The composition of the R-motif peptides is given at the top of each pair of images; R is arginine; and X is any other amino acid.**DOI:** [http://dx.doi.org/10.7554/eLife.13571.003](10.7554/eLife.13571.003)10.7554/eLife.13571.004Figure 1---figure supplement 1.Representative ITC curves for titrations of multivalent R-motif containing peptides into N122 and N130.**DOI:** [http://dx.doi.org/10.7554/eLife.13571.004](10.7554/eLife.13571.004)10.7554/eLife.13571.005Figure 1---figure supplement 2.Multivalent R-motifs reside in disordered regions of proteins.IUPRED predictions of protein disorder. The location of R-motif peptides is highlighted. rpL5 and rpL23 structures have been resolved in the context of the assembled ribosome, where they adopt helical structures in complex with other ribosomal proteins and rRNA. In isolation, however, these structural features may not be highly populated.**DOI:** [http://dx.doi.org/10.7554/eLife.13571.005](10.7554/eLife.13571.005)

Results {#s2}
=======

NPM1 interacts with proteins displaying multivalent R-rich linear motifs {#s2-1}
------------------------------------------------------------------------

We first investigated interactions of R-motif-containing proteins with NPM1 by analyzing the results of a whole cell NPM1 pull-down experiment (see Materials and Methods). Of 132 NPM1-binding proteins, 97% exhibited at least one R-motif (RX~n1~R, where X is any amino acid and n~1~ ≤ 2; [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}) and 78.8% were annotated with GO terms indicating association with membrane-less organelles ([Supplementary file 2](#SD2-data){ref-type="supplementary-material"}). Amongst all 132 NPM1-binding proteins, 73% exhibited multiple R-motifs ([Supplementary file 1](#SD1-data){ref-type="supplementary-material"}); in contrast, only 44% of all human proteins exhibited multiple R-motifs (p\<0.0001; [Supplementary file 3](#SD3-data){ref-type="supplementary-material"}). Thus, multivalent R-motifs are enriched in proteins that bind to NPM1.

Multivalent R-rich linear motifs mediate phase separation with NPM1 {#s2-2}
-------------------------------------------------------------------

R-motifs bind to a region of NPM1 which includes the OD and a short disordered region (residues 1--130; termed N130; [Figure 2a](#fig2){ref-type="fig"}). The interactions engage two highly conserved acidic tracts, termed A1 (residues 34--39) and A2 (residues 120--130), at the interface between monomer subunits and within the disordered region ([@bib50]), respectively ([Figure 2a](#fig2){ref-type="fig"}). These A tracts and the pentameric nature create multivalency within N130. Multivalent interactions involving low complexity sequences cause assembly and phase separation of biopolymers within membrane-less organelles ([@bib23]; [@bib44]); therefore, we tested the ability of multivalent N130 and peptides containing multiple R-motifs derived from NPM1-binding proteins to undergo phase separation. Titration of four R-motif-containing peptides ([Table 1](#tbl1){ref-type="table"}) caused phase separation into liquid-like droplets ([Figure 1b](#fig1){ref-type="fig"} and [Videos 1](#media1){ref-type="other"}--[4](#media4){ref-type="other"}) at critical concentrations that varied with R-motif composition and affinity for N130 ([Table 2](#tbl2){ref-type="table"} and [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). At 200 µM N130, upon titration of the divalent rpL5 peptide, phase separation was observed when the rpL5:N130 ratio reached \~3:1 ([Figure 2b](#fig2){ref-type="fig"}). At the same N130 concentration, phase separation was not observed upon titration of a monovalent R-motif peptide (rpL5-RA; [Figure 2b](#fig2){ref-type="fig"}), even though it bound, albeit with lower affinity ([Table 2](#tbl2){ref-type="table"} and [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), confirming that R-motif multivalency is required for phase separation with N130. The inability to phase separate was not due to reduced binding affinity (rather than loss of multivalency); a poly-R peptide, containing a single but longer R-motif, with affinity similar to that of rpL5, also failed to phase separate ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Additionally, phase separation was not observed when an NPM1 construct containing only the OD (N122, residues 1--122; [Figure 2a](#fig2){ref-type="fig"}) was titrated with the rpL5 peptide ([Figure 2c](#fig2){ref-type="fig"} and [Table 2](#tbl2){ref-type="table"}). We thus conclude that the minimal multivalency requirements for phase separation are the acidic A1 and A2 tracts within NPM1 and at least two complementarily charged R-motifs within a polypeptide binding partner.10.7554/eLife.13571.006Figure 2.Multivalency within both the rpL5 peptide (of R-motifs) and N130 (or A tracts) is required for phase separation.(**a**) Schematic representation of the NPM1 constructs used in this study; (**b**) Titrations of rpL5 (blue) or rpL5-RA peptide lacking the second R-motif (red), into 200 μM N130, monitored by light scattering at 340 nm; (**c**) Titrations of rpL5 peptide into N130 (blue) and N122 (orange).**DOI:** [http://dx.doi.org/10.7554/eLife.13571.006](10.7554/eLife.13571.006)10.7554/eLife.13571.007Figure 2---figure supplement 1.A monovalent peptide with similar affinity to rpL5 for binding N122 does not phase separate with N130.(**a**) ITC curve of 6R peptide titrated into N122; (**b**) Light scattering assays of divalent rpL5 (blue), monovalent rpL5- RA (red) and monovalent, but tighter binding 6R (aqua).**DOI:** [http://dx.doi.org/10.7554/eLife.13571.007](10.7554/eLife.13571.007)10.7554/eLife.13571.008Table 1.Amino acid sequences of the synthetic multivalent R-motif containing peptides.**DOI:** [http://dx.doi.org/10.7554/eLife.13571.008](10.7554/eLife.13571.008)Peptide\
Name^\#^Peptide amino acid sequencerpL5^21^RRRREGKTDY~10~YARKRLV^37^GNL2^682^RRRAVRQQRP~10~KKVGVRYYET~20~HNVKNRNR^709^SURF6^299^RRAQRQRRWE~10~KRTAGVVEKM~20~QQRQDRRR^326^rpL23a^47^RRPKTLRLRR~10~QPKYPRKSAP~20~RR^68^rpL5-RA^21^RRRREGKTDY~10~YAAKALV^37^rpL5-2xLinkerRRRREGKTDY~10~YAEGKTDYYA~20~RKRLV[^2]Video 1.In vitro droplets formed between 100 µM N130 and 500 µM rpL5. 1 µM N130 was labeled with AlexaFluor488.**DOI:** [http://dx.doi.org/10.7554/eLife.13571.009](10.7554/eLife.13571.009)10.7554/eLife.13571.009Video 2.In vitro droplets formed between 25 µM N130 and 70 µM GNL2. 1 µM N130 was labeled with AlexaFluor488.**DOI:** [http://dx.doi.org/10.7554/eLife.13571.010](10.7554/eLife.13571.010)10.7554/eLife.13571.010Video 3.In vitro droplets formed between 100 µM N130 and 200 µM SURF6. 1 µM N130 was labeled with AlexaFluor488.**DOI:** [http://dx.doi.org/10.7554/eLife.13571.011](10.7554/eLife.13571.011)10.7554/eLife.13571.011Video 4.In vitro droplets formed between 50 µM N130 and 80 µM rpL23. 1 µM N130 was labeled with AlexaFluor488.**DOI:** [http://dx.doi.org/10.7554/eLife.13571.012](10.7554/eLife.13571.012)10.7554/eLife.13571.01210.7554/eLife.13571.013Table 2.Binding affinities for interactions between N122 (NPM1 residues 1--122, displaying only A1) and N130 (displaying both A1 and A2) and the multivalent R-motif-containing peptides, determined using isothermal titration calorimetry (ITC), at concentrations below the critical phase separation threshold.**DOI:** [http://dx.doi.org/10.7554/eLife.13571.013](10.7554/eLife.13571.013)PeptideN122N130N (sites)K~D~ (μM)N (sites)K~D~ (μM)rpL50.63 ± 0.0919.0 ± 2.72.18 ± 0.1920.5 ± 5.0GNL20.66 ± 0.0410.2 ± 1.3n.d.^\*^n.d.^\*^SURF60.55 ± 0.069.2 ± 0.51.4 ± 0.0219.0 ± 0.8rpL23an.d.^\#^n.d.^\#^n.d.^\*^n.d.^\*^rpL5-RA1.0 ± 0.0650.9 ± 3.180.84 ± 0.07140.1 ± 9.29[^3][^4][^5]

Mutivalent R-peptides mediate inter-pentamer cross-linking in liquid-like droplets {#s2-3}
----------------------------------------------------------------------------------

Next, to understand the mechanism of phase separation, we characterized the structural features of complexes of rpL5 with N130 before and after droplet formation. Fluorescence anisotropy (FA) of a N130^S125C^ mutant, labeled with Alexa Fluor594 within A2, increased in a biphasic manner upon titration of rpL5 ([Figure 3a](#fig3){ref-type="fig"}). Results from small-angle neutron scattering (SANS) and analytical ultracentrifugation (AUC) experiments showed that monodisperse, soluble complexes formed at the first FA transition, which occurred at \~1:1 rpL5:N130 stoichiometry ([Figure 3a](#fig3){ref-type="fig"}, inset; [Figure 3a--c](#fig3){ref-type="fig"}; [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}; [Table 3](#tbl3){ref-type="table"}). Nuclear magnetic resonance (NMR) spectroscopy showed that rpL5 bound to both the A1 and A2 tracts within ^15^N-N130 ([@bib50]) with a global K~D~ of 57 ± 14 µM (see Analysis methods) in agreement with isothermal titration calorimetry measurements ([Table 2](#tbl2){ref-type="table"}). Site-specific K~D~ values calculated from chemical shift perturbations of individual N130 peaks upon titration with rpL5 ([Figure 4a](#fig4){ref-type="fig"}) are presented in [Table 4](#tbl4){ref-type="table"}. We investigated NMR transverse dipole-dipole/CSA cross relaxation and longitudinal relaxation for backbone amide moieties in ^2^H/^15^N-N130 titrated with rpL5 to determine their dynamic parameters before phase separation ([Figure 4b,c](#fig4){ref-type="fig"}). Residues within the A2 tract of the apo state, analyzed separately from the folded pentameric core (see Analysis methods), experienced fast, local motions \[average local correlation time ($\tau_{c,local}$), 2.10 ± 0.05 ns; average local order parameter ($S_{f}^{2}$), 0.44 ± 0.01\]; these motions were slowed when N130 was \~93% saturated with rpL5 ($\tau_{c,local}$, 4.56 ± 0.06 ns; [Table 5](#tbl5){ref-type="table"}) and were reduced in amplitude ($S_{f}^{2}$, 0.76 ± 0.01; [Table 5](#tbl5){ref-type="table"}). Furthermore, a comparison of the overall tumbling time for core residues of N130 in the free and 93% rpL5 saturated state indicated 2:1 binding stoichiometry (see Analysis methods).10.7554/eLife.13571.014Figure 3.The liquid-like phase formed by rpL5 and N130 is characterized by molecular ordering and is accompanied by soluble, oligomeric intermediates.(**a**) Fluorescence anisotropy of Alexa Fluor594-labeled N130 (at S125C within acidic tract A2; 1 μM) upon titration of the rpL5 peptide; the total \[N130\] was 200 μM. Insets: light microscopy images of the 1:1 (cyan box), 2:1 (green box) and 3:1 (red box) rpL5:N130 solutions. The same stoichiometry color coding is used in all panels. (**b**) SANS curves, *I(q) versus q*, for rpL5:N130 (200 μM) solutions at 0:1, 1:1, 2:1, and 3:1 stoichiometry. The curve for the 0:1 solution is on the absolute *I(q*) scale (cm-1) with the others shifted in 1, 2 and 4 decade increments for clarity. Fits (solid lines) of the curves to obtain R~g~ values (0:1 and 1:1 solutions) and correlation distances (2:1 and 3:1 solutions) are shown (See Analysis methods for details on curve fitting). (**c**) Pair-distribution, *P(r*), curves for 0:1 and 1:1 rpL5:N130 were calculated from the corresponding SANS curves (fits shown in [Figure 3b](#fig3){ref-type="fig"}). For apo N130, the *D*~max~ \~ 78.65 Å with a resulting *R*~g~ = 23.04 ± 0.09 Å and *I*(0) = 0.2344 ± 0.0006 cm^-1^. From *I*(0) and using Eq. S1, the estimated molecular mass, *M* = 76 kDa, was determined; this mass is consistent with the expected five subunits within the pentamer (subunit *M* = 14.6 kDa). For 1: 1 rpL5:N130, the *D*~max~ \~ 80.32 Å with a resulting *R*~g~ = 24.3 ± 0.1 Å and *I*(0) = 0.2744 ± 0.0009 cm^-1^. Here, *I*(0) yields *M* = 89 kDa, indicative of \~5 rpL5 (*M* = 2.2 kDa) molecules bound to N130.**DOI:** [http://dx.doi.org/10.7554/eLife.13571.014](10.7554/eLife.13571.014)10.7554/eLife.13571.015Figure 3---figure supplement 1.Sedimentation velocity analytical ultracentrifugation (SV-AUC) profiles for N130 titrated with rpL5.SV-AUC profiles for apo N130 (purple), or N130 with rpL5 at 1:1 (light blue), 2:1 (green) and 3:1 (red) stoichiometric ratio (rpL5:N130).**DOI:** [http://dx.doi.org/10.7554/eLife.13571.015](10.7554/eLife.13571.015)10.7554/eLife.13571.016Table 3.Results of sedimentation velocity analytical centrifugation analysis (SV-AUC) of N130 in the absence or presence of increasing concentrations of the rpL5 peptide.**DOI:** [http://dx.doi.org/10.7554/eLife.13571.016](10.7554/eLife.13571.016)rpL5:N130mg/ml^a^s~20~ (Svedberg)^b^s~20,w~ (Svedberg)^c^MW (kDa)^d^f/f~0~ ^e^0:12.764.63 (98.7%)4.8288.91.537.90 (1.20%)8.22198.01.531:13.095.23 (96.3%)5.4499.31.467.63 (3.7%)7.94175.01.462:1 (1-300 min)3.631.07 (2.6%)1.116.81.205.80 (48%)6.0386.31.208.11 (23%)8.44143.01.2012.33 (25%)12.82268.01.2014-19 (7%)14-19300-5001.202:1 (100-300 min)^f^3.315.75 (56%)5.9881.11.165.80 (25%)6.03128.01.168.11 (17%)8.44182.01.163:1 (1-300 min)2.010.95 (17%)0.987.41.435.80 (31%)6.00112.01.4310.32 (32%)10.73266.01.4314-27 (21%)14-27500-8501.433:1 (100-300 min)^f^1.291.18 (4%)1.221.11.495.73 (41%)5.96117.01.497.41 (20%)7.71173.01.499.17 (15%)9.54238.01.4911.33 (15%)11.79266.01.49[^6][^7][^8][^9][^10][^11]10.7554/eLife.13571.017Figure 4.NMR chemical shift perturbations and amide backbone relaxation analysis of apo N130 and soluble complexes at 2.5:1 rpL5:N130 stoichiometry.(**a**) ^1^H-^15^N TROSY-HSQC spectra of apo N130 (magenta), in a soluble complex with rpL5 (2.1:1 rpL5:N130; green) and in the phase separated state (4:1 rpL5:N130; red). (**b**) Examples of R~2,β~ and R~2,α~ peak intensity decay curves measured at 800 MHz (i) and 1000 MHz (ii), and R1 peak intensity decay curves measured at 800 MHz (iii) for free N130. In (i) and (ii), points and curves in black and red correspond to the R~2,β~ and R~2,α~ experiments, respectively. In (i)--(iii), circles and squares indicate data points for residues Tyr29 (within the folded pentamer core) and Glu121 (within the disordered A2 tract), respectively. Solid lines correspond to fits using a simple exponential decay model from which relaxation rates and intensities at zero time were extracted. (**c**) (i) Comparison of S2 values for the N-terminus for which data could be collected for apo N130 (magenta bars) and 2.5:1 rpL5:N130 (green bars). Comparison of $\tau$~c,local~ (ii) and S2 (iii) values for C-terminal residues in apo N130 (magenta bars) and 2.5:1 rpL5:N130 (green bars). S125 is overlapped in the apo N130 spectrum; therefore, under this condition, these analyses could not be performed.**DOI:** [http://dx.doi.org/10.7554/eLife.13571.017](10.7554/eLife.13571.017)10.7554/eLife.13571.018Table 4.NMR-derived dissociation constant (K~D~) values determined by monitoring chemical shift perturbations of individual N130 nitrogen backbone resonances while titrating the rpL5 peptide.**DOI:** [http://dx.doi.org/10.7554/eLife.13571.018](10.7554/eLife.13571.018)ResidueStructural contextK~D~ (μM)Met5N-terminus385 ± 108Asp6N-terminus116 ± 25Met7N-terminus142 ± 30Ser10N-terminus56 ± 13Leu12N-terminus10 ± 5Arg13N-terminus58 ± 13Gln15Core36 ± 10Tyr17Core19 ± 9Leu18Core205 ± 51Val33Core1041 ± 649Asp36A1 tract329 ± 93Glu37A1 tract1549 ± 1168Glu39A1 tract115 ± 37His40Core123 ± 23Leu42Core24 ± 9Ser43Core166 ± 38Ala64Core1227 ± 562Asn66Core1530 ± 958Tyr67Core245 ± 58Glu68Core147 ± 29Val74Core53 ± 14Phe92Core14 ± 6Glu93Core329 ± 78Ile94Core73 ± 17Thr95Core34 ± 9Leu116Core101 ± 24Val117Core61 ± 17Ala118Core35 ± 9Glu120A2 tract68 ± 16Glu121A2 tract101 ± 18Asp122A2 tract279 ± 76Ala123A2 tract182 ± 50Glu124A2 tract614 ± 410Glu126A2 tract576 ± 471Asp127A2 tract2162 ± 1612Glu130A2 tract4258 ± 198610.7554/eLife.13571.019Table 5.NMR-derived dynamic parameters for monodisperse apo N130 and a 2.5:1 rpL5:N130 soluble complex.**DOI:** [http://dx.doi.org/10.7554/eLife.13571.019](10.7554/eLife.13571.019)Apo N130\
(N-terminus/A2 tract)2.5:1 rpL5:N130\
(N-terminus/A2 tract)$\tau_{c,local}\operatorname{}$**(ns)**\--^a^ / 2.10 ± 0.05\--^a^ / 4.56 ± 0.06$S_{f}^{2}$0.16 ± 0.01^a^ / 0.44 ± 0.010.26 ± 0.02^a^ / 0.76 ± 0.01[^12]

The second transition in the FA curve (starting at \~2.5:1 rpL5:N130) corresponded to phase separation ([Figure 3a](#fig3){ref-type="fig"}). To gain insight into conformational changes associated with phase separation, we performed single-molecule Förster resonance energy transfer ( smFRET) experiments with a mutant of N130, N130^Q15C/S125C^, that could be dually labeled with Alexa Fluor594 & 680 at sites within the pentamer core (Q15C) and the A2 acidic tract (S125C), respectively. The FRET efficiency (E~FRET~) for this dye pair within the droplet phase (E~FRET~ \~0.15) was dramatically reduced in comparison with that observed in the absence of rpL5 (E~FRET~ \~0.85; [Figure 5](#fig5){ref-type="fig"}), consistent with the extension of the A2 tract from the N130 pentamer core due to interactions with rpL5 molecules upon phase separation ([Figure 6a](#fig6){ref-type="fig"}). In contrast to the monodisperse character of the SANS curves for samples of rpL5 and N130 at 0:1 and 1:1 (rpL5:N130) stoichiometry ([Figure 3b,c](#fig3){ref-type="fig"}), the curve for the 1:3 sample indicated periodic structural organization within the liquid-like droplets ([Figure 3b](#fig3){ref-type="fig"}, red curve). We interpreted these features in terms of inter-molecular correlation distances (55 Å, 77 Å, and 119 Å; see Analysis methods) due to organization of N130 and rpL5 induced by phase separation. Notably, nascent, higher order structural organization was evident in the SANS curve for a solution of rpL5 and N130 with 2:1 stoichiometry ([Figure 3b](#fig3){ref-type="fig"}, green curve). Assembly of rpL5 and N130 into higher order, soluble intermediates at and above the 2:1 stoichiometric ratio was also demonstrated using sedimentation velocity analytical ultracentrifugation (SV-AUC; [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}, [Table 3](#tbl3){ref-type="table"}). The appearance of high molecular weight species within the detection range (\<1 MDa) was accompanied by a progressive decrease in the total mass detected, likely due to sedimentation of rpL5:N130 droplets in the sample cell during the dead-time of the experiment. Above the phase separation threshold (\>3:1 rpL5:N130), resonances for residues within the N130 core broadened beyond detection in 2D ^1^H-^15^N TROSY spectra but not those for residues within the A2 tract ([Figure 4a](#fig4){ref-type="fig"}). Chemical shift values indicated that these residues remained disordered.10.7554/eLife.13571.020Figure 5.The A2 tract extends away from the folded core of N130 on the pathway to phase separation.smFRET histograms for Alexa Fluor594/680-labeled N130^Q15C/S125C^ (\~100 pM; total \[N130\], 200 μM) at 0:1, 0.5:1, 2.7:1 and 3:1 (phase separated state) rpL5:N130 stoichiometry; the FRET events corresponding to conformational states with similar E~FRET~ values are indicated by the shaded regions. The solid lines are Gaussian fits of the data, from which average E~FRET~ values were determined.**DOI:** [http://dx.doi.org/10.7554/eLife.13571.020](10.7554/eLife.13571.020)10.7554/eLife.13571.021Figure 6.Schematic model of the structural rearrangements in N130 associated with liquid-liquid phase separation in the presence of the multivalent rpL5 peptide.(**a**) Structural representation of results from NMR and smFRET that revealed dramatic changes in dynamics and spatial orientation of the A2 track of N130 upon rpL5 peptide binding: apo N130 (top) and N130 in complex with rpL5 (bottom). Residues within the A2 tract of N130 are shown as colored spheres with diameters proportional to the $\tau_{c,\operatorname{}local}$ value for the ^15^N nucleus of amide group. The sites of fluorescent labeling, Q15C and S125C, are indicated as purple and yellow spheres, respectively (the spheres for Q15C do not encode dynamic information). In the apo state, A2 randomly samples relatively compact conformations, while in liquid-like droplets, these residues extend away from the N130 core. (**b**) Schematic representation of apo N130 (**i**) and the proposed structural model of phase separation. Upon saturation of the two principal binding sites within the A1 and A2 tracts on N130 (**ii**), bound rpL5 peptides extend toward and engage in weak interactions with neighboring N130 pentamers (**iii**), thus creating 3D, expandable cross-links. In (**iii**), only a subset of the possible inter-N130 pentamer crosslinks are shown for clarity. We suggest that one of the correlation distances observed using SANS (77 Å) corresponds to the inter-N130 pentamer spacing.**DOI:** [http://dx.doi.org/10.7554/eLife.13571.021](10.7554/eLife.13571.021)

Integrating our structural results, we propose a model of rpL5/N130-dependent phase separation, as follows ([Figure 6b](#fig6){ref-type="fig"}). As rpL5 is titrated into N130 up to 2:1 stoichiometry (rpL5:N130), the R1 motifs, comprised of four Arg residues each, bind to acidic residues within the A1 binding groove and disordered A2 tract of N130, with the R2 motif available for interactions. Upon further titration of rpL5, at the critical phase separation concentration, when the higher affinity sites reach a critical saturation threshold, R2 motifs within rpL5 molecules already bound to N130 pentamers transiently engage A tracts of other pentamers, possibly within the longer and disordered A2 tract, establishing inter-N130 pentamer cross-links. Together, our data support the hypothesis that the molecular basis of phase separation is the formation of non-covalent, inter-N130 pentamer interactions via the two R-motifs within the same rpL5 peptide molecule. We propose that these rpL5-mediated interactions establish the inter-pentamer spacing within the droplet phase that was detected by SANS ([Figure 3b](#fig3){ref-type="fig"}). In order to validate this model, we synthesized a variant rpL5 peptide in which the eight residue-long linker connecting the two R-motifs (see [Table 1](#tbl1){ref-type="table"}) was duplicated. The phase separated sample formed between the peptide with the longer linker (rpL5-2xLinker) exhibited altered inter-molecular spacing, as indicated by altered correlation distances derived from the SANS curve ([Figure 7](#fig7){ref-type="fig"}). These shifted to positions corresponding to larger correlation distances, in agreement with the hypothesis that the R-motif peptides establish inter-N130 pentamer spacing in the liquid-like phase. We envision that such cross-links are dynamically formed and broken but that, once phase separation occurs, they dominate the structural organization detected by SANS.10.7554/eLife.13571.022Figure 7.The length of the linker between R-motifs in the rpL5 peptide influences the molecular organization within rpL5:N130 liquid-like droplets.(**a**) SANS curves, *I(q) versus q*, for 3:1 rpL5:N130 (red) and rpL5-2xLinker:N130 (orange) solutions; the N130 concentration for both was 200 μM. The curve for the droplets containing rpL5 2xLinker is displayed on absolute *I(q*) scale (cm^-1^) with the curve corresponding to rpL5 containing droplets shifted in 4 decade increments for clarity. Fits (solid lines) of the curves to obtain correlation distances are shown (See Analysis methods for details on curve fitting). Peak positions for the droplets with the rpL5-2xLinker correspond to correlation distances (*d*) of 63 Å & 100 Å whereas those observed with the wild-type rpL5 peptide correspond to *d* values of 56 Å, 79 Å & 119 Å. *Inset:* wide-field fluorescence microscopy (left) and DIC (right) images of droplets formed from the 3:1 rpL5-2xLinker:N130 solution. Scale bar = 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.13571.022](10.7554/eLife.13571.022)

NPM1 incorporates both R-rich peptides and rRNA into multicomponent liquid-like droplets {#s2-4}
----------------------------------------------------------------------------------------

Our data showed that the minimal construct, N130, supported droplet formation. However, both the OD ([@bib18]; [@bib33]) and NBD ([@bib29]; [@bib51]) are required for nucleolar localization of transfected NPM1, suggesting that interactions with ribosomal RNA (rRNA) are also involved in integration of NPM1 within the GC matrix. Full length NPM1 also exhibits a central intrinsically disordered region (IDR) that, in addition to the A2 tract, contains a longer acidic tract termed A3 ([Figure 1a](#fig1){ref-type="fig"}). We tested and confirmed the ability of full length NPM1 (N294) to phase separate with either wheat germ rRNA or rpL5 using light scattering ([Figure 8a & b](#fig8){ref-type="fig"}, respectively) and fluorescence microscopy ([Figure 9a](#fig9){ref-type="fig"}, Rows 1 & 2, respectively). Binary mixtures of N294 with either rpL5 or rRNA formed droplets that increased in size over time ([Figure 9b](#fig9){ref-type="fig"}); those with rpL5 fused more rapidly and were larger in size than those with rRNA. Furthermore, droplets of NPM1 with rpL5 formed at \~5-fold lower concentrations of both components ([Figure 8b](#fig8){ref-type="fig"}) than were required for phase separation with N130 and rpL5 ([Figure 1b](#fig1){ref-type="fig"}) due to the higher valency of acidic tracts within the full-length protein. Interestingly, rpL5 (and other R-motif peptides) and rRNA phase separated in the absence of N294 ([Figure 8c,d](#fig8){ref-type="fig"}), forming very small puncta ([Figure 9a](#fig9){ref-type="fig"}, Row 3). We cannot explain the physical basis for the different dynamics of liquid-like droplets formed by N294 with either rRNA or rpL5 ([Figure 9a](#fig9){ref-type="fig"}, Rows 1 and 2, respectively) or the morphology of the punctate structures formed by rRNA and rpL5 ([Figure 9a](#fig9){ref-type="fig"}, Rows 3) due to the lack of data on the interaction between NBD of NPM1 or rpL5, and rRNA (*i.e.,* binding affinities, number and location of binding sites, etc.). The size difference between the two types of droplets with N294 ([Figure 9a](#fig9){ref-type="fig"}, Rows 1 and 2) may, however, arise from differences in binding affinity between rRNA and NBD *versus* rpL5 and A tracts within OD/IDR.10.7554/eLife.13571.023Figure 8.Phase separation by pairwise mixtures of NPM1 (N294) and molecules representing two fundamental components of the nucleolus, R-motif containing proteins (represented by R-motif peptides) and rRNA, as determined by light scattering assays.Titration of (**a**) N294 into 50 μg/mL rRNA and (**b**) rpL5 into 40 μM N294; (**c**) Titrations of rRNA into 50 μM R-motif containing peptides (rpL5, GLN2, SURF6, and rpL23a). (**d**) Titrations of R-motif containing peptides into 50 μg/mL rRNA (as in **c**).**DOI:** [http://dx.doi.org/10.7554/eLife.13571.023](10.7554/eLife.13571.023)10.7554/eLife.13571.024Figure 9.Multi-modal binding of NPM1 mediates formation of liquid-like droplets with both rRNA and rpL5 in vitro.(**a**) Confocal microscopy images of droplets after 15 min incubation formed between 40 μM N294 and 50 μg/mL rRNA (Row 1), 40 μM N294 and 200 μM rpL5 (Row 2), 200 μM rpL5 and 50 μg/mL rRNA (Row 3) and 40 μM N294 and 50 μg/mL rRNA droplets treated with 40 μM rpL5, a concentration below the critical phase separation threshold for N294/rpL5 binary system (Row 4). rpL5 and N294 were labeled with Alexa Fluor594 and Alexa Fluor488, respectively. Scale bar = 10 μm; (**b**) Quantitation of droplet size over time for the samples presented in panel **a**; values plotted are the mean ± SD, n = 4 fields of view.**DOI:** [http://dx.doi.org/10.7554/eLife.13571.024](10.7554/eLife.13571.024)

Intrigued by the physical differences between the structures formed by pairwise combinations of N294, rpL5 and rRNA, we next sought to understand the behavior of these three species in ternary mixtures by examining interactions between pre-formed droplets comprised of N294 and rRNA to which freely diffusing rpL5 was added, at a concentration below that which caused phase separation with N294 alone ([Figure 9a](#fig9){ref-type="fig"}, Row 4). The peptide accumulated into the rRNA/N294 droplets, highlighting NPM1's capacity to bind the two fundamental classes of macromolecules present in the nucleolus; these droplets also slowly grew over time ([Figure 9b](#fig9){ref-type="fig"}). Importantly, this multi-modal binding mediates the co-assembly of rRNA and rpL5 within a dense, multi-component liquid-like phase. We hypothesize that a similar molecular mechanism is responsible for the phase separation and co-localization of nucleolar components within the GC.

We next examined the roles of the different domains of NPM1 in phase separation to form multi-component liquid-like droplets using two truncation mutants, one lacking the NBD (N240, residues 1--240; [Figure 2a](#fig2){ref-type="fig"}) and another lacking the OD (ΔN, residues 120--294; [Figure 2a](#fig2){ref-type="fig"}). In agreement with a mechanistic model wherein multivalent interactions between pentameric A1, A2, and A3 tracts within NPM1 and multivalent R-motifs within its nucleolar protein partners mediate phase separation, the N240, but not the ΔN construct phase separated with rpL5 ([Figure 10a](#fig10){ref-type="fig"}). Furthermore, neither of these truncated constructs experienced phase separation in the presence of rRNA, confirming that multivalent display of the NBD is required for the co-localization of rRNA with NPM1 within liquid-like droplets ([Figure 10b](#fig10){ref-type="fig"}).10.7554/eLife.13571.025Figure 10.The OD and A tracts of NPM1 are required for phase separation with rpL5, while phase separation in the presence of rRNA requires both folded domains (OD & NBD).Light scattering assays of (**a**) titrations of rpL5 peptide into 40 μM NPM1 and (**b**) titrations of NPM1 constructs into 50 μg/mL rRNA. Values plotted are the mean ± SD, n = 3 experiments. The dashed line at 0.1 AU indicates the threshold, above which visible turbidity and microscopic droplets can be detected.**DOI:** [http://dx.doi.org/10.7554/eLife.13571.025](10.7554/eLife.13571.025)

Multi-modal binding to two classes of macromolecules, R-motif-containing nucleolar proteins (binding mode 1) and rRNA (binding mode 2), is likely critical for NPM1-dependent formation of multi-component liquid-like droplets. In the absence of NPM1, rRNA and rpL5, representing these two classes, phase separated into small puncta ([Figure 8c,d](#fig8){ref-type="fig"}, [Figure 9](#fig9){ref-type="fig"}). Given this result, we next asked whether addition of NPM1 constructs to these puncta would cause reorganization and co-localization of the constituent macromolecules within larger, liquid-like droplets. In order to differentiate between the effects of interactions between the OD/A tracts and rpL5 (mode 1) and OD/NBD and rRNA mode (mode 2) on phase separation, we first formed rRNA/rpL5 puncta at two concentrations of rpL5 and then added the NPM1 constructs and monitored phase separation using confocal-microscopy. At the high rpL5 concentration (rpL5, 200 μM; NPM1 constructs, 30 μM; termed the \'excess\' condition), rpL5 and NPM1 could independently phase separate. However, at the low concentration (rpL5, 50 μM; NPM1 constructs, 30 μM; termed the \'limiting\' condition), rpL5 and NPM1 could not independently phase separate. The addition of N294 to pre-formed, rpL5/rRNA puncta caused spontaneous formation of large droplets under conditions of both limiting and excess rpL5, whose sizes increased with increasing N294 concentration ([Figure 11](#fig11){ref-type="fig"}). In contrast, addition of the N240 deletion construct, lacking the NBD, caused phase separation under conditions of excess rpL5, but not with a limiting amount of rpL5 ([Figure 11](#fig11){ref-type="fig"}). Finally, addition of the ΔN construct, lacking the OD and therefore displaying dramatically reduced multivalency, failed to cause phase separation under both excess and limiting rpL5 conditions ([Figure 11](#fig11){ref-type="fig"}). Together, these results support a mechanism wherein the high valency associated with the NPM1 OD, together with the multiple acidic tracts and NBD, are required for the dissolution of rpL5/rRNA puncta and co-localization of these molecules within large liquid-like droplets that readily grow in size. We thus propose that, through multi-modal interactions with two major classes of nucleolar macromolecules, NPM1 localizes to the nucleolus and also mediates the co-localization of other protein-binding partners and rRNA within the GC of the nucleolus.10.7554/eLife.13571.026Figure 11.Both the OD and NBD of NPM1 are required for co-localization of rRNA and rpL5 within liquid-like droplets in vitro.Confocal microscopic images 15 min after the addition of the specified NPM1 construct (30 μM) to preformed rpL5/rRNA puncta formed from 50 μg/mL rRNA and 200 μM rpL5 (**a**) and from 50 μg/mL rRNA and 50 μM rpL5 (**b**). Scale bar = 10 μm. Quantification of the growth of droplets formed through disassembly of rpL5/rRNA puncta upon addition of individual NPM1 constructs. (**c**) NPM1 constructs were titrated into puncta formed between 200 μM rpL5 and 50 μg/mL rRNA, where rpL5 is above the threshold for independent phase separation with NPM1. The star at 40 μM N294 indicates that the droplets experienced wetting on the slide surface and expanded above the maximum threshold of 100 μm^2^ set in the analysis; (**d**) NPM1 constructs titrated into puncta formed between 50 μM rpL5 and 50 μg/mL rRNA, where rpL5 is below the threshold for independent phase separation with NPM1.**DOI:** [http://dx.doi.org/10.7554/eLife.13571.026](10.7554/eLife.13571.026)

R-motif and nucleic acid binding by pentameric NPM1 are both required for nucleolar localization {#s2-5}
------------------------------------------------------------------------------------------------

We next explored the relevance of our in vitro findings to nucleolar physiology. First, we monitored the accumulation of a series of recombinant eGFP-fused NPM1 constructs within isolated nucleoli ([Figure 12a](#fig12){ref-type="fig"}) using confocal fluorescence microscopy. Consistent with in vitro results showing that all domains of NPM1 were required for the integration of both an R-motif peptide and rRNA into large, liquid-like droplets, the eGFP-N294 fusion protein accumulated within purified nucleoli, even at sub-micromolar concentrations ([Figure 12b,c](#fig12){ref-type="fig"}), while constructs lacking either the rRNA binding or oligomerization domains (eGFP-N240 or eGFP-△N, respectively) did not ([Figure 12c](#fig12){ref-type="fig"}). These results suggested that the nucleolar localization of NPM1 requires multi-modal interactions with both R-motif-containing nucleolar proteins and rRNA.10.7554/eLife.13571.027Figure 12.Synergistic activity of the OD and NBD are required for NPM1 incorporation in mammalian nucleoli.(**a**) DIC image of isolated nucleoli; (**b**) Titrations of recombinant eGFP-N294 into purified nucleoli. Fluorescence intensity over background is quantified. (**c**) Fluorescence profile through sections of nucleoli treated with 100 μM recombinant eGFP-NPM1 constructs. Values in panels (**b**) and (**c**) represent mean ± SD, n = 20 nucleoli; (**d**) Fluorescence confocal microscopy images of MEF cell lines; DAPI was imaged to identify nuclei, mCherry to identify the NPM1 constructs, and a fluorescently-labeled antibody to NOPP140 to identify the GC of nucleoli. Scale bar = 5μm.**DOI:** [http://dx.doi.org/10.7554/eLife.13571.027](10.7554/eLife.13571.027)10.7554/eLife.13571.028Figure 12---figure supplement 1.The multi-modal binding properties of the OD and NBD of NPM1 are required for localization within mammalian nucleoli.Confocal fluorescence microscopy images of *Trp53*^-/-^ and *Npm1*^-/-^/*p53*^-/-^ (DKO) MEF cell lines, and DKO cell lines stably expressing mCherry-fused NPM1 constructs, stained with DAPI to visualize nuclei and with a fluorescent antibody for fibrillarin to visualize nucleoli. NPM1-expressing cells were also imaged for mCherry fluorescence. Scale bar = 5 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.13571.028](10.7554/eLife.13571.028)10.7554/eLife.13571.029Figure 12---figure supplement 2.Flow cytometric analysis of transduced MEFs.(**a**) Surface expression of Thy1.1 was analyzed in parental (filled histogram) and DKO MEFs transduced with empty vectors (mock; black curve) or those containing mCherry NPM1 variants: N294 (red), N240 (green) and ΔN (blue). (**b**) The expression of mCherry was determined in Thy1.1-expressing cells (right panel).**DOI:** [http://dx.doi.org/10.7554/eLife.13571.029](10.7554/eLife.13571.029)

To extend our studies to the cellular setting, we next investigated the domain requirements for nucleolar localization by creating *Trp53*^-/-^/*N*pm*1*^-/-^ mouse embryonic fibroblasts cell lines (DKO MEFs) that stably expressed a related series of mCherry-fused NPM1 constructs. The parental DKO cell line was created by replacing exons 2--7 of *Npm1* with *eGFP*, and therefore constitutively expresses the fluorescent protein ([@bib24]). The stable DKO MEF cell lines were created through infection with retroviruses carrying the Thy1.1 cell surface marker in frame with an internal ribosomal entry site (IRES) and an mCherry-NPM1 variant gene. The two genes are translated from the same bicistronic mRNA transcript at similar levels ([@bib27]). Therefore, the Thy1.1 cell surface marker is an unbiased reporter of mCherry-NPM1 variant expression. mCherry is primarily localized to the cytoplasm and is stable in cells ([@bib59]); therefore, with the constructs under study here, any alteration of its localization and stability can be attributed to its NPM1 variant fusion partner. In agreement with the *in vitro* and *ex cellulo* results, full length mCherry-NPM1 accumulated in nucleoli and co-localized with the nucleolar markers NOPP140 ([Figure 12d](#fig12){ref-type="fig"}) and fibrillarin ([Figure 12---figure supplement 1](#fig12s1){ref-type="fig"}). Despite the fact that all cell lines expressed comparable levels of the Thy1.1 marker ([Figure 12---figure supplement 2](#fig12s2){ref-type="fig"}), and all NPM1 constructs encode the native bi-partite nuclear localization signal (residues 152--157 and 191--197 \[[@bib28]\]), mCherry fluorescence was undetected in the mCherry-N240 cell lines, while the mCherry-ΔN cell lines exhibited diffuse mCherry fluorescence throughout the nucleus ([Figure 12d](#fig12){ref-type="fig"} and [Figure 12---figure supplement 1](#fig12s1){ref-type="fig"}). Notably, Enomoto, *et al.,* previously showed that NPM1 mutants which lacked the ability to accumulate within nucleoli exhibited dramatically reduced half lives in cells ([@bib18]), a potential explanation for the undetectable levels of mCherry-N240 in our study. We note that our observations through use of DKO cell lines contrast with those of others ([@bib18]; [@bib51]) wherein NPM1 constructs lacking the C-terminal domain accumulated within nucleoli. These previous studies are confounded by the possiblility for the formation of heteromeric oligomers comprised of endogenous wild-type and mutant NPM1 proteins. Collectively, these data suggest that nucleolar localization of NPM1 is achieved only when interactions with both R-motif-containing nucleolar proteins and rRNA are possible. Deletion of either the NBD or OD abrogated the ability of NPM1 to simultaneously interact with an R-motif-containing peptide and rRNA within droplets *in vitro* ([Figure 11](#fig11){ref-type="fig"}), suggesting that co-localization of NPM1 with the two types of nucleolar components in dense liquid-like droplets and localization within nucleoli arise through similar mechanisms involving multi-modal, multivalent interactions that promote phase separation.

Discussion {#s3}
==========

The nucleolus is a membrane-less organelle comprised of a vast array of macromolecules that mediate ribosome biogenesis and participate in stress signaling. However, the molecular mechanism that underlies the localization of macromolecules within the nucleolus is poorly understood. In contrast to the nuclear localization process, for example, which relies on nuclear transport receptors that recognize their cargo via a specific short linear motif ([@bib13]) and transport them across the nuclear membrane through the nuclear pore complex, there are no known molecular transporters that mediate localization of proteins to the nucleolous. It has been hypothesized that enrichment of proteins within the nucleolus occurs though selective retention within the nucleolar matrix. Short basic sequences, termed nucleolar localization signals (NoLS), often rich in R and lysine (K) residues, have been identified experimentally to be necessary and, in some cases, sufficient for localization of certain proteins within the nucleolus ([@bib58]). However, the molecular basis for how these canonical signals cause nucleolar localization is presently unknown. Here, we identified multivalent, low complexity R-motifs within proteins that are associated with binding to the abundant nucleolar protein, NPM1. Furthermore, we showed that these multivalent R-motifs underwent phase separation with NPM1 to form dense, liquid-like droplets, and became co-localized within these types of droplets that also contained rRNA. Strikingly, the multivalent R-motifs that we identified to mediate interactions with NPM1 have features in common with the canonical NoLSs: they are enriched in basic amino acids and are often located within disordered and solvent accessible regions of proteins ([@bib58]) ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). This observation, however, raises several questions. Do the links between canonical NoLSs and nucleolar localization, and multivalent R-motifs and NPM1 binding, have a common mechanistic basis? And, does nucleolar localization rely on the ability of proteins to experience phase separation within a multi-component, liquid-like phase? To address these questions, we compared our list of NPM1 interacting proteins that contained multivalent R-motifs with the database of all predicted NoLSs within the human proteome (\[[@bib58]\]; <http://www.compbio.dundee.ac.uk/www-nod/downloads/AllPredictedHumanNoLSs.txt>). Interestingly, 83 (63%) of the proteins from our curated list of NPM1 interactors corresponded to those with predicted NoLSs. Of these 83, 69 (83%) contained 2 or more R-motifs, and there was extensive overlap between the sequence locations of the multivalent R-motifs that we identified and those of the predicted NoLSs ([Supplementary file 1](#SD1-data){ref-type="supplementary-material"}). Based on these observations, we propose that canonical NoLSs, which closely match our definition of multivalent R-motifs, enable proteins that are freely diffusing through the nuclear compartment to phase separate within the nucleolar matrix, thereby mediating their nucleolar localization.

Furthermore, while the NoLSs described by Scott, *et al.,* account for the nucleolar localization of hundreds of proteins, more than 4,500 proteins are known to reside within the nucleolus ([@bib2]), highlighting the need to identify additional localization mechanisms. Interestingly, along these lines, NPM1, although well established to be highly enriched in the nucleolus, does not exhibit a canonical NoLS. Rather, here we describe a multi-modal interaction model that enables the multifunctional protein NPM1 to interact with R-motif-containing proteins and rRNA, representative of two major classes of macromolecules resident of the nucleolus. In support of this, we found that disruption of its multi-modal interactions, through abrogation of NBD oligomerization by the deletion of the OD or removal of the NBD, hindered NPM1's ability to phase separate *in vitro* and to accumulate in nucleoli within mammalian cells ([Figures 10](#fig10){ref-type="fig"}--[12](#fig12){ref-type="fig"}). Consistent with our model, a previously described putative NoLS involves two buried Trp residues which are essential for proper folding of the NBD ([@bib25]). Mutations of these residues destabilized the NBD, thereby impeding interactions with nucleic acids and nucleolar localization ([@bib5]; [@bib12]; [@bib19]; [@bib25]). Thus, we propose that multi-modal binding by NPM1 may play an important role in the structural organization of the nucleolus and the recruitment of proteins to the nucleolus.

In our structural studies of the minimal phase separating system, N130/rpL5, we showed that within the liquid-like matrix of the droplets, with diameters on the microns to tens of microns length scale, we observed local ordering on the length scale of 5 to 12 nanometers ([Figures 3](#fig3){ref-type="fig"} and [7](#fig7){ref-type="fig"}). We propose that the intermolecular spacing indicated by SANS is dictated, at least in part, by the length of the linker connecting the two R-motifs in the divalent rpL5 peptide. Another factor in the spatial organization within these droplets is the 5-fold symmetry of the A1 binding grooves within the N130 pentamer that bind R-motifs within the rpL5 peptide ([Figure 1](#fig1){ref-type="fig"} and \[[@bib50]\]). We suggest that the SANS data indicate the \'persistence length\' of local structural order that, despite constant formation and dissociation of R-motif peptide-mediated cross-links, is sufficient to provide \'structure\' to the liquid-like droplets. However, for several reasons, this is likely a highly simplified view of NPM1 structural organization within the GC of the nucleolus. First, NPM1's binding partners display diverse patterns of multivalent R-motifs ([Supplementary file 1](#SD1-data){ref-type="supplementary-material"}), providing many ways of forming cross-links with NPM1. Second, in comparison with N130, full length NPM1 exhibits the A3 acidic tract within the IDR, enabling additional interactions with R-motifs within proteins, and the NBD, that can bind to rRNA. Therefore, due to these factors, NPM1's structural organization within the nucleolus is likely highly heterogeneous, in contrast to the orderly organization of N130 within droplets with rpL5. This model for the the structurally heterogenous integration of NPM1 within the nucleolar matrix provides a mechanistic explanation for its central role in many nucleolar functions, such as ribosome biogenesis and nucleolar stress responses ([@bib45]).

Through studies of an *in vitro* model system based upon formation of multi-component liquid-like droplets, representing a simplified form of the GC of the nucleolus, we identified three fundamental types of interactions that mediated phase separation: (1) R-motifs (from nucleolar proteins) binding to oligomeric, multivalent A-tracts (within NPM1), (2) low complexity multivalent R-motifs binding to rRNA and (3) oligomeric, folded nucleic acid binding domains (within NPM1) binding to rRNA. Disrupting either type (1) or (3) interactions abrogated accumulation of NPM1 within nucleoli ([Figure 12](#fig12){ref-type="fig"}), demonstrating the relevance of our *in vitro* findings to the physiological setting. Complete loss of NPM1 from nucleoli (e.g., in the *Trp53*^-/-^/*Npm1*^-/-^ mouse embryonic fibroblasts cells) did not, however, preclude other nucleolar proteins (NOPP140 and fibrillarin; [Figure 12](#fig12){ref-type="fig"} and [Figure 12---figure supplement 1](#fig12s1){ref-type="fig"}, respectively) from accumulating within punctate nuclear structures, in support of a model wherein collective interactions between many different nucleolar components drive their assembly into dense liquid-like structures.

While the R-motif-rich sequences are recognized to be associated with nucleolar localization ([@bib58]), the other two protein features identified in our study to be important for interactions with nucleolar components, namely multivalent acidic tracts and multivalent, folded nucleic acid binding domains, are not. Notably, the association of multivalency mediated by homo-oligomerization and acidic low complexity regions with phase separation is, to the best of our knowledge, unique to NPM1. We expect, however, that similar features may be utilized by other proteins for incorporation into the nucleolar matrix. For example, NOPP140, known to be localized within the GC, exhibits 11 acidic, serine-rich clusters (\[[@bib62]\]; <http://www.uniprot.org/uniprot/Q14978>). Furthermore, nucleolin, which also lacks a canonical NoLS, exhibits 3 acidic tracts (with lengths between 15 and 29 amino acids), 4 tandem folded RNA recognition motifs in addition to multivalent R-motifs (\[[@bib62]\]; <http://www.uniprot.org/uniprot/P19338>), which may mediate multi-modal binding to protein and rRNA components within the dense liquid-like phase of the nucleolus. While the established NoLS is consistent with our mechanistic model for nucleolar localization, other proteins, which we suggest function by contributing to the structural organization of the nucleolus, such as NPM1, are not encompassed by this definition. We propose that the three fundamental types of interactions noted above mediate the localization of a wide veriety of proteins, along with rRNA, within the liquid-like structure of the nucleolus, providing new perspective on the term \'nucleolar localization signal\'.

Materials and methods {#s4}
=====================

Bioinformatics analysis of NPM1 binding proteins {#s4-1}
------------------------------------------------

A list of 132 NPM1 binding partners obtained from BioGRID (deposited by Dr. Steven Gygi, Harvard Medical School; available at <http://thebiogrid.org/166968/publication/high-throughput-proteomic-mapping-of-human-interaction-networks-via-affinity-purification-mass-spectrometry.html>) was analyzed using the DAVID Bioinformatics Resources (<http://david.abcc.ncifcrf.gov>) ([@bib31]; [@bib32]) to identify proteins with known involvement in nucleolar structure and/or function. GO terms were available for 125 of the 132 NPM1-binding proteins ([Supplementary file 2](#SD2-data){ref-type="supplementary-material"}). To gain insight into the molecular basis for interactions with NPM1, we determined the occurrence of multivalent R-motifs within the sequences of the 132 NPM1-binding proteins. Minimal R-motifs were defined as follows: a minimal, single R-motif as the sequence pattern, RX~n1~R, where n1≤2, R is arginine and X is any amino acid; a minimal, multivalent R-motif as the sequence pattern, RX~n1~RX~n2~RX~n3~R, where n1, n3≤2, and n2≤20) ([Supplementary file 1](#SD1-data){ref-type="supplementary-material"}). In [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}, the identified R-motifs were extended if followed by another Arg residue within two or fewer residues. A Python algorithm, available for download at [https://github.com/dlaszlo88/eLIFE-NPM_NMRrelaxation](https://urldefense.proofpoint.com/v2/url?u=https-3A__github.com_dlaszlo88_eLIFE-2DNPM-5FNMRrelaxation&d=AwMGaQ&c=SgMrq23dbjbGX6e0ZsSHgEZX6A4IAf1SO3AJ2bNrHlk&r=mGUktg4mqnLlkXOWfJr_XEd0PDTc05030RvYTeM9DgM&m=NhkNRd_SRzKAw9f31GGdTqDCw1SPKictNKXolQFhqq8&s=8a0VIv_pzl_jYd7ufZ40OVrNI_p3rxQj-bRb63NVvHY&e=) was developed to identify proteins exhibiting multivalent R-motifs and was applied to the list of NPM1 binding proteins as well as a list of 20,193 non-redundant human proteins obtained from the UniProtKB/Swiss-Prot database (<http://www.uniprot.org/uniprot/>) ([@bib62]). Of the 132 NPM1 binding partners, 73% exhibited at least one multivalent R-motif; in comparison, only 44% of all human proteins exhibited at least one multivalent R-motif ([Supplementary file 3](#SD3-data){ref-type="supplementary-material"}). These data show NPM1 binding partners are enriched in multivalent R motifs, when compared to the majority of the human proteome (p\<0.0001).

Cloning, protein expression and purification {#s4-2}
--------------------------------------------

The N130 protein was expressed and purified as described ([@bib50]). The eGFP-NPM1 constructs were subcloned in the pET28 vector (Novagen, Darmstadt, Germany), with an N-terminal poly-His tag. eGFP was amplified from pEGFP-C1, a gift from Dr. Douglas Green, and inserted between NdeI and BamHI restriction sites. NPM1 construct genes, derived from human NPM1, were cloned between BamHI and XhoI restriction sites. The original Thrombin cleavage site following the affinity tag was replaced with a PreScission cleavage site. Proteins were expressed in *E. Coli* strain BL21(DE3) in Luria Broth. Protein expression was induced at OD~600~ \~0.6 with 100 mg/L IPTG (Goldbio, St. Louis, MO) and the cultures were incubated overnight at 20 °C. Bacterial pellets were harvested by centrifugation and lysed by sonication in 20 mM Tris, 150 mM NaCl, 5 mM β-mercapto-ethanol (BME), pH 7.5, supplemented with protease inhibitors (SigmaFAST, Sigma-Aldrich, St. Louis, MO). eGFP-NPM1 proteins were further purified using Ni-NTA affinity chromatography, using 0.5 M NaCl in the buffers. The eluted proteins were dialysed overnight against 10 mM Tris, 50 mM NaCl, 2 mM DTT pH 7.5 in the presence of HRV3C protease (BioVision, Milpitas, CA) to remove the poly-His tag and further purified on a Mono Q HR 5/5 (GE Healthcare, Pittsburgh, PA) ion exchange column, followed by size exclusion chromatography on HiLoad 26/60 Superdex 200 (GE Healthcare, Pittsburgh, PA) in 10 mM Tris, 150 mM NaCl, 2 mM DTT, pH 7.5. The N122 construct was a gift from Dr. Yuh Min Chook (UT Southwestern, Dallas). The protein was expressed with an N-terminal GST tag as described above. The N122 protein was affinity purified on a reduced glutathione agarose column (Qiagen, Hilden, Germany), followed by GST tag proteolysis with thrombin and finally purified to homogeneity using size exclusion chromatography, as described above.

Peptide synthesis {#s4-3}
-----------------

Peptides were synthesized in house, by the Macromolecular Synthesis resource within the Hartwell Center for Bioinformatics and Biotechnology at St. Jude Children's Research Hospital, using standard solid phase peptide synthesis chemistry.

Phase transition assays by light scattering {#s4-4}
-------------------------------------------

The samples were incubated at room temperature for 5 min and UV-Vis absorbance spectra were recorded in triplicate on a NanoDrop 2000c spectrophotometer (Thermo Scientific, Waltham, MA).

Fluorescent labeling {#s4-5}
--------------------

N130 was labeled with Alexa Fluor488 C~5~ maleimide (Life Technologies, Carlsbad, CA), according to the manufacturer's protocol. The labeling was performed in 10 Tris, 150 mM NaCl, pH 7.5 buffer to maintain N130 in its folded pentameric state ([@bib50]) and ensure selective labeling at solvent exposed Cys104, thereby avoiding labeling the buried Cys21. The rpL5 peptide was N-terminally labeled using Alexa Fluor594 Succinimidyl ester (Life Technologies, Carlsbad, CA) following the manufacturer's protocol.

Isothermal titration calorimetry {#s4-6}
--------------------------------

Titrations were performed using a GE Auto-iTC200 instrument (Malvern, Malvern, UK), at 25 °C, with the NPM1 construct in the cell. Proteins and peptides were dialyzed overnight against the reaction buffer, consisting of 10 mM Na phosphate, 150 mM NaCl, 2 mM DTT, pH 7.0. The concentrations were selected to be below the phase separation threshold and were determined from A~280nm~ of the protein or peptide diluted in 6 M guanidine hydrochloride buffer.

Fluorescence spectroscopy {#s4-7}
-------------------------

N130 constructs with Q15C and S125C single and double mutations in the background of a C104T mutation were used. For ensemble fluorescence anisotropy measurements, N130 labeled at C125 with Alexa Fluor594 (C~5~ maleimide derivative; Life Technologies, Carlsbad, CA) was used. The protein was labeled in 10 mM Na phosphate, 500 mM NaCl, pH 7.5 with 2-fold molar excess of the dye overnight at 4 °C in the dark. For dual labeling of N130 at C15 and C125, the following protocol was used: a 2-fold molar excess of donor dye (Alexa Fluor594 C5-maleimide derivative, Life Technologies, Carlsbad, CA), and a 8-fold molar excess of the acceptor dye (Alexa Fluor680 C2-maleimide derivative, Life Technologies, Carlsbad, CA) were incubated together in 10 mM Na phosphate, 500 mM NaCl, pH 7.5 overnight at 4 °C for in the dark. The excess dye in all labeling reactions was removed by multiple rounds of washing with the labeling buffers using a 3K MWCO centrifugal filter device (Millipore, Darmstadt, Germany). The purity of all the samples was confirmed by ESI-mass spectroscopy (Scripps Center for Mass Spectrometry). Ensemble fluorescence measurements were carried out using an automated temperature controlled PC1 spectrofluorometer (ISS, Champaign, IL) in 10 mM Tris, 150 mM NaCl, pH 7.5. The single-molecule fluorescence measurements were performed on freely diffusing molecules with a 532 nm excitation line (CrystaLaser, Reno, NV) (operating on a 500 µW power) using a home-built instrument. The details of smFRET instrumentation, data collection and data analysis have been described elsewhere ([@bib21]; [@bib22]). All experiments were performed at room temperature in 10 mM Tris, 150 mM NaCl, 2 mM DTT, pH 7.5 using a dual-labeled protein concentration of \~100 pM in the presence of 200 µM unlabeled N130. To minimize photobleaching, 0.5% N-propyl gallate (final concentration) was used from a 200x concentrated stock in acetonitrile.

NMR spectroscopy {#s4-8}
----------------

For all NMR experiments, the N130 construct was used. Samples of perdeuterated, ^15^N uniformly labeled, N130 were dissolved in 90% H~2~O/10% D~2~O containing 10 mM sodium phosphate buffer at pH 7.0 with 150 mM NaCl and 5 mM DTT. All experiments were performed at 298 K. TROSY-HSQC based titration experiments were collected with a Bruker Avance I spectrometer operating at a Larmor frequency of 800 MHz (Bruker, Billerica, MA). ^15^N backbone relaxation experiments which measured the transverse cross-relaxation and longitudinal relaxation rates were performed on the free and bound N130 at static magnetic fields of 600, 800 and 1000 MHz. For N130 in the droplet state the same experiments were performed, but only at 600 and 800 MHz. Data were processed and visualized using NMRPipe and CARA, respectively. Fits to all NMR data for the extraction of parameters describing the observed motion were performed using in-house written scripts in Python and Mathematica (Wolfram Research, Champaign, IL). All scripts are available for download at available for download at [https://github.com/dlaszlo88/eLIFE-NPM_NMRrelaxation](https://urldefense.proofpoint.com/v2/url?u=https-3A__github.com_dlaszlo88_eLIFE-2DNPM-5FNMRrelaxation&d=AwMGaQ&c=SgMrq23dbjbGX6e0ZsSHgEZX6A4IAf1SO3AJ2bNrHlk&r=mGUktg4mqnLlkXOWfJr_XEd0PDTc05030RvYTeM9DgM&m=NhkNRd_SRzKAw9f31GGdTqDCw1SPKictNKXolQFhqq8&s=8a0VIv_pzl_jYd7ufZ40OVrNI_p3rxQj-bRb63NVvHY&e=). See below for details on all NMR experiments and analysis.

Analytical ultracentrifugation {#s4-9}
------------------------------

Sedimentation velocity experiments were conducted in a ProteomeLab XL-I analytical ultracentrifuge (Beckman Coulter, Indianapolis, IN) following standard protocols unless mentioned otherwise ([@bib57]; [@bib70]). The samples in a buffer containing 10 mM NaP pH 7.0, 150 mM NaCl, and 2 mM DTT were loaded into a cell assembly comprised of a double sector charcoal-filled centerpiece with a 12 mm path length and sapphire windows. The cell assembly, containing identical sample and reference buffer volumes of 380 µL, was placed in a rotor and temperature equilibrated at rest at 20 °C for 2 hr before it was accelerated from 0 to 40000 rpm. Rayleigh interference optical data were collected continuously for 12 hr, 400 min for 1:0 and 1:1 and 300 min for 1:2 and 1:3 and analyzed. The velocity data were modeled with diffusion-deconvoluted sedimentation coefficient distributions c(s) in SEDFIT (<https://sedfitsedphat.nibib.nih.gov/software/default.aspx>), using algebraic noise decomposition and with signal-average frictional ratio and meniscus position refined with non-linear regression. The s-value was corrected for time, temperature and radial position and finite acceleration of the rotor was accounted for in the evaluation of Lamm equation solutions ([@bib71]). Maximum entropy regularization was applied at a confidence level of P-0.68.

Small-angle neutron scattering {#s4-10}
------------------------------

SANS experiments were performed on the extended Q-range small-angle neutron scattering (EQ-SANS, BL-6) beam line at the Spallation Neutron Source (SNS) located at Oak Ridge National Laboratory (ORNL). In 30 Hz operation mode, a 4 m sample-to-detector distance with 2.5--6.1 and 9.4--13.4 Å wavelength bands was used ([@bib69]) to obtain the relevant wavevector transfer, *q* = 4π sin(θ)/λ, where 2θ is the scattering angle. rpL5:N130 samples at 0:1, 1:1, 2:1, and 3:1 mol ratios were prepared in 10 mM Tris, 150 mM NaCl, 2 mM DTT D~2~O (pH measured = 7.5). The samples were loaded into 2 mm pathlength circular-shaped quartz cuvettes (Hellma USA, Plainville, NY) and SANS measurements were performed at 25 °C. Data reduction followed standard procedures using MantidPlot ([@bib4]). The measured scattering intensity was corrected for the detector sensitivity and scattering contribution from the solvent and empty cells, and then placed on absolute scale using a calibrated standard ([@bib65]).

Light microscopy of in vitrodroplets {#s4-11}
------------------------------------

Wide field DIC and 488 nm fluorescence images used for phase separation assays with the N130 construct were collected on a Nikon C1Si microscope (Nikon Instruments, Melville, NY) using a 60x 1.45 NA magnification oil objective. 10 µl samples were incubated at room temperature for 5 min prior to analysis. Droplets were defined as having an area greater than 9 squared pixels (0.2 μm/pixel) and circularity 0.5--1. Particles smaller than 9 squared pixels were visible by fluorescence but not DIC at low protein and peptide concentrations; however, these objects were below the threshold to confidently measure circularity. Therefore, droplets formation was not recorded until particles could be observed by DIC.

For ternary mixture assays, the various AlexaFluor488-tagged NPM1 constructs were titrated into the mixtures of rRNA and rpL5 peptide. Confocal images of phase separation droplets were collected on Nikon C1Si (Nikon Instruments, Melville, NY) or Zeiss Axio Observer (Carl Zeiss Microscopy, Jena, Germany) microscopes, using a 60X 1.45 NA or 63X 1.40 NA oil magnification objective, respectively, in μ-slide VI^0.4^ 6 channel flow cells (ibidi, Madison, WI) or CultureWell 16-well chambered coverglass (Grace Biolabs, Bend, OR), coated with PlusOne Repel-Silane ES (GE Healthcare, Pittsburgh, PA). Images of MEFs and isolated nucleoli were recorded on a Zeiss Axio ObserverZ.1 microscope equipped with a CSU-22 spinning disk (Yokagawa, Tokyo, Japan), Delta Evolve EMCCD camera and 100X 1.45 NA oil objective.

Isolation of nucleoli {#s4-12}
---------------------

Nucleoli were prepared from Cos7 cells (ATCC number CRL 1651) using an established protocol ([@bib55]). Briefly, 1 x 10^7^ cells were harvested by trypsin digestion followed by serum inactivation and washing in two exchanges of PBS. Cells were incubated in nucleolar isolation buffer (NIB; 10 mM Tris, 2 mM MgCl~2~, 0.5 mM EDTA, pH 7.5) for 2 min at room temperature followed by 10 min on ice. The cells were disrupted by the addition of NP-40 to a final concentration of 1%. The mixture was centrifuged for 3 min at 500 x g to collect the nuclear fraction, followed by washing in NIB containing NP-40 prior to resuspension in buffer without additional NP-40. The nuclear suspension was sonicated on ice at 20% power for 12 cycles of 1 s ON / 5 s OFF, using a 1/8'' tip on a Fisher Scientific Model 505 Sonic Dismembrator (Thermo Fisher Scientific, Waltham, MA). Nucleoli were collected as the pellet by centrifugation at 4 °C, 500 x g, for 3 min and resuspended in NIB. The integrity of purified nucleoli was verified by (i) morphology and (ii) distribution of established nucleolar proteins via immunostaining and confocal microscopy. We note that incubation in the presence of 150 mM NaCl to match the physiological millieu caused isolated nucleoli to dissolve.

Cell culture {#s4-13}
------------

*Trp53*^-/-^ and *NPM1*^-/-^ / *Trp53*^-/-^ (DKO) MEF cell lines were a kind gift from Drs. C. Sherr (St. Jude Children's Research Hospital) and P. Pandolfi (Beth Israel Deaconess Medical Center). Retroviruses were produced by transfecting the Thy1.1-IRES-mCherry-NPM1 variant plasmids or the empty vector into Phoenix cells, using Xfect transfection reagent (Clontech Laboratories, Mountain VIew, CA), in 6 well plates. We note that all Phoenix cells harboring plasmids that encoded for mCherry exhibited red fluorescence under the light microscope. Transfected cells were incubated overnight at 37 °C in a 5% CO~2~ atmosphere. The supernatant containing viruses was collected, filtered through a 0.45 µm seringe filter, and transferred immediately onto 6 well plates seeded with 8 x 10^4^ DKO MEFs, in the presence of 5 µg/mL polybrene. Infections were carried twice a day, for a total of five infections. Virally transduced cells were sorted based on Thy1.1 expression using FACS; sorted cells were expanded in culture.

Flow Cytometry {#s4-14}
--------------

MEFs were trypsinized using 0.05% trypsin + EDTA prior to resuspension in PBS containing 1% BSA and 1 mM EDTA. Cells were surface labeled with APC-conjugated anti-Thy1.1 (clone OX-7; Biolegend, San Diego, CA) at \[0.4 ng/ml\] for 30 min on ice. Following incubation, cells were washed three times prior to resuspension in PBS containing 1 mM EDTA and analysis using a Fortessa cytometer (BD Biosciences, San Jose, CA).

Image processing {#s4-15}
----------------

Enrichment of eGFP-tagged NPM1 constructs in purified nucleoli was determined using Slidebook 6.0 (Intelligent Imaging Innovations, Gottingen, Germany). Briefly, each nucleolus was bisected with a line of 80 pixels in length, based on the DIC image. The resulting fluorescence intensity of each pixel along the line was plotted according to pixel position.

For the quantification of droplet size, the lower and upper limits of fluorescence intensity were matched for all images in Slidebook 6.0 and the particle count was subsequently performed in ImageJ, as follows: 24-bit RGB images were converted into 8-bit images, background subtraction and auto threshold were applied, images were converted to mask and merged objects were separated using the binary watershed operation. Particles were analyzed using Analyze Particles, imposing the size restriction of 5--2500 pixel (\~100 µm^2^) and the circularity restriction 0.2--1. \>90% of all observed droplets had areas within the selected window and were included in the analysis, unless otherwise noted; \>50 particles were counted per image.

Immunostaining {#s4-16}
--------------

Purified nucleoli were allowed to settle onto poly-D-Lysine-coated chambered coverslips prior to fixation for 10 min with 4% paraformaldehyde in PBS. Nucleoli were subsequently treated for 10 min with cold acetone at -20 °C prior to incubation with blocking buffer (20 mM Tris pH 8.0, 100 mM NaCl, 2% bovine serum albumin, 0.05% Tween-20) for 30 min. The samples were stained overnight at 4 °C in blocking buffer containing anti-Fibrillarin (Novus Biologicals, Littleton, CO; NB300-269, 2.5 μg/mL), anti-rpL5 (Santa Cruz Biotech, Dallas, TX; sc-103865, 2 μg/mL) and anti-NPM (Abgent, San Diego, CA; AP2834b, 1:200 dilution) antibodies. The samples were washed in 20 mM Tris pH8.0, 100 mM NaCl and 0.05% Tween-20 prior to detection with fluorescently labeled secondary antibodies (Life Technologies, Carlsbad, CA) and imaged using a Zeiss Axio Observer Z.1 equipped with a CSU-22 spinning disk, Delta evolve EMCCD camera and 100X 1.45NA oil objective, and Slidebook 6.0 (Intelligent Imaging Innovations, Gottingen, Germany).

MEFs were seeded onto 4-well chambers at 40000 cells/well and incubated overnight at 37 °C, in 5% CO~2~ incubator. Cultured MEFs were fixed in 4% methanol-free paraformaldehyde for 10 min at room temperature, followed by incubation in TBS (20 mM Tris, 100 mM NaCl) containing 0.3 M glycine for 10 min. The cells were permeabilized for 3 min in TBS containing 0.1% Triton-100, followed by 30 min incubation in TBS containing 2% bovine serum albumin. The slides were incubated overnight at 4 ° with anti-Fibrillarin (clone 38F3; Genetex, Irvine, CA) or anti-Nopp140 (sc-28672, Santa Cruz Biotech, Dallas, TX) antibodies each at \[1 ng/ml\] diluted in TBS + 2% BSA. Primary antibodies were detected with either AF647-labeled goat anti-Mouse (ThermoFisher) or AF647-labeled goat anti-Rabbit (ThermoFisher) secondary antibodies at \[1 ug/ml\] for 1 hr at room temperature. Samples were post-fixed in 1% PFA after washing, and prior to imaging in TBS containing 1 ug/ml Hoescht (Thermo Fisher Scientific, Walthman, MA). Images were acquired using a Marianas spinning-disk laser scanning confocal (Intelligent Imaging Innovations) comprising a Zeiss AxioObserverZ.1 equipped with a 63x 1.4NA objective and Evolve EMCCD camera (Photometrics, Tucson, AZ).

Analysis methods {#s4-17}
----------------

### SANS data analysis {#s4-17-1}

#### 0:1 and 1:1 rpL5:N130 {#s28}

Upon verifying a Guinier regime ([@bib26]) in the rpL5:N130 0:1 and 1:1 SANS profiles, the pair distance distribution function, *P(r*), was calculated from the scattering intensity, *I(q*), using the indirect Fourier transform method implemented in the GNOM program ([@bib60]) ([Figure 3b](#fig3){ref-type="fig"}). The *P(r*) function was set to zero for *r* = 0 and *r* = *D*~max~, the maximum linear dimension of the scattering object. *D*~max~ was explored to optimize the *P(r*) solution and excellent quality solutions were found in each case. The real-space radius of gyration, *R*~g~, and scattering intensity at zero angle, *I*(0), were determined from the *P(r*) solution to the scattering data. The molecular mass, *M*, was calculated by

$$I\left( 0 \right) = \frac{cM}{N_{A}}\left( \mathrm{\Delta}\rho \right)^{2}\overline{\vartheta}$$

where *c* = protein concentration (= 3 mg/mL), △*ρ* = contrast in scattering length density between protein and D~2~O buffer solution (= *ρ*~prot~ -- *ρ*~D2O~), $\overline{\vartheta}$ = protein partial specific volume (= 0.73 ml/g), and *N*~A~ = Avogadro's number. The N130 scattering length density, *ρ*~prot~, (= 3.0 × 10^10^ cm^-2^) was calculated from the sequence using CRYSON ([@bib61]). The D~2~O scattering length density used was *ρ*~D2O~ = 6.404 × 10^10^ cm^-2^.

#### 2:1 rpL5:N130 {#s29}

The rpL5:N130 2:1 SANS curve was fit to an empirical broad peak model implemented in the NCNR SANS package ([@bib36]) for Igor Pro software where the scattering intensity is:

$$I\left( q \right) = \frac{A}{q^{n}} + \frac{C}{\left( {\operatorname{}{q - q_{0}}\operatorname{}}\xi \right)^{m}} + B$$

to yield the Porod scale, *A* (= (3.1 ± 0.3) x 10^-5^), and exponent, *n* (=2.68 ± 0.02), Lorentzian scale, *C* (=0.0394 ± 0.0007), peak position, *q*~0~ (=0.0740 ± 0.0004 Å^-1^), screening length, ξ (=36.7 ± 0.5 Å), and exponent, *m* (=3.46 ± 0.07), and background, *B (=* (--3 ± 2) x 10^-4^cm^-1^). The peak position corresponds to a *d*-spacing (*d*~0~ = 2π/*q*~0~) of 85 Å.

#### 3:1 rpL5:N130 {#s30}

A portion of the rpL5:N130 3:1 SANS curve was fit to three Gaussian peaks using the multi-peak fitting routine within Igor Pro software and yielded peak maxima at *q*~1~ = 0.0528 Å^-1^, *q*~2~ = 0.0820 Å^-1^, and *q*~3~ = 0.1140 Å^-1^ with corresponding *d*-spacings (*d*~i~ = 2π/*q*~i~) of *d*~1~ = 119 Å, *d*~2~ = 77 Å, and *d*~3~ = 55 Å, respectively.

NMR analysis of ^2^H/^15^N-N130; apo, bound to rpL5 in the solution phase, and bound to rpL5 in liquid-like droplets {#s4-18}
--------------------------------------------------------------------------------------------------------------------

### Characterization of rpL5 binding to ^2^H/^15^N-N130 in the solution phase state; NMR-based titration {#s4-18-1}

N130 for all NMR samples was maintained at a monomer concentration of 284 μM. NMR-based chemical shift titrations of N130 with rpL5 peptide were performed in a step-wise manner in which a stock of highly concentrated peptide was added incrementally to the N130 samples. A total of nine additions were performed over which the dilution of the N130 was small changing the overall volume of the sample by only 2%. rpL5 was titrated into a sample with N130 up to a \[rpL5\]:\[N130\] ratio of 3:1 (maximum concentration of rpL5 was 870 μM). All titration experiments were collected with a Bruker Avance I spectrometer operating at a Larmor frequency of 800 MHz. For apo N130 and with each addition of rpL5 a TROSY type amide proton, nitrogen two-dimensional correlation spectrum was recorded. Spectra were collected with 100 and 1024 complex points in the indirect and direct dimension yielding maximum acquisition times of 12.1 ms and 91.8 ms, respectively. Incremental additions of rpL5 allowed for the extraction of binding isotherms by monitoring the change in the ^15^N chemical shift (△ω~15N~) as a function of ligand concentration ([Table 4](#tbl4){ref-type="table"}). Binding isotherms were fit to a simple two-state binding model and used to extract the dissociation constant (K~D~) of the interaction ([@bib9]). Although N130 displayed a range of site-specific K~D~ values ([Table 4](#tbl4){ref-type="table"}), we established criteria for the selection of isotherms that were considered for the global determination of the K~D~, as follows.

First, only nuclei whose △ω~15N~ exceeded 0.15 ppm by the end of the titration were considered. This yielded a total of 36 individual binding isotherms. Second, for each binding isotherm, the last five points were normalized with respect to their final observed △ω~15N~ during the titration (△ω~15N~ at a \[rpL5\]:\[N130\] at 3:1) and fit to a straight line. Slopes from these fits that were close to zero indicated flat binding isotherms at the end of the titration and ^15^N nuclei that had reached saturation (e.g., their chemical shifts do not change significantly at higher \[rpL5\]:\[N130\] ratios). ^15^N nuclei whose slope was less than the average were pooled and used for a global analysis of the K~D~ value. This provided a total of 18 binding isotherms which were fit to a single K~D~ value and to each binding isotherm's individual maximum △ω~15N~. The global analysis was implemented in Mathematica (Wolfram Research, Champaign, IL) and yielded a global K~D~ value of 57 ± 14 μM and is similar to the K~D~ value determined using isothermal titration calorimetry (21 ± 5 μM; [Table 2](#tbl2){ref-type="table"}). We appreciate that for a given pentamer each monomeric unit consists of two possible binding sites (A1 & A2 tracts; [Figure 1a](#fig1){ref-type="fig"}) and the current use of a simple two-state binding model does not distinguish between these two sites. The extension to higher order binding models that represent multiple independent binding sites may be necessary, but the binding isotherms collected here do not display multiple independent binding events and thus only a two-state model was applied ([@bib3]). Error bars for all individual and global fits were determined from Monte-Carlo simulations in which a 10% error in the absolute peptide concentration (effectively shifting points along the abscissa) was considered and 500 random binding isotherms were generated and subsequently refit ([@bib49]). The standard deviation in parameters from these simulations was used as the error for these measurements.

### Method for analysis of fast pico- to nanosecond motions in apo N130 and solution phase rpL5:N130 complexes {#s4-18-2}

We sought quantitative, atomic resolution information on the dynamic features of ^2^H/^15^N-N130 in three different states: apo form, bound to rpL5 in the solution phase, and bound to rpL5 in liquid-like droplets. Since solution NMR is uniquely suited to probe motions with atomic detail, we exploited a combination of NMR relaxation experiments that report on motions faster than the overall rotational correlation time (τ~c~). Conventional NMR relaxation experiments which probe fast pico- to nanosecond timescale motion can be used to obtain information on internuclear vector flexibility (S^2^) and molecular time constants related to rotational diffusion processes ([@bib53]). These experiments, when combined, can be used to extract τ~c~, S^2^, and time constants such as the fast lifetimes of internal motion (τ~f~; picoseconds), and in some cases motion in the low nanosecond range if τ~c~ is much greater than this additionally \'slow\' nanosecond motion (denoted as τ~s~). However, for high molecular weight proteins like N130 (the molecular weight of the pentamer is 73.4 kDa), the study of backbone ^15^N nuclei dynamics is challenging due to slow molecular tumbling. In order to overcome this, we utilized experiments analogous to Lakomek, *et al*., ([@bib39]) that utilize the TRACT ([@bib43]) concept in which the slowly (β) and fast relaxing (α) transverse components of the ^15^N doublet were individually queried and their rate of decay measured within conventional TROSY-type HSQC experiments in order to obtain the relaxation rates for both components. Measurement of both R~2,β~ and R~2,α~ permits the calculation of the transverse cross-relaxation rate, η~xy~, which reports on motions up to τ~c~ and in addition contains no contribution of slow ms-μs motional processes due to chemical exchange ([@bib43]). For the extraction of parameters that define the observed relaxation processes, we also recorded longitudinal relaxation (R~1~) experiments for backbone ^15^N nuclei which have small values for large molecular weight proteins to increase the number of observables ([@bib41]). The inclusion of R~1~ values in our analysis was critical because this relaxation rate samples contributions of high frequency motions for backbone ^15^N nuclei that η~xy~ does not ([@bib37]). The approach described above was necessary because high quality intrinsic relaxation rate (R~2,0~) and ^15^N heteronuclear-NOE data could not be recorded due to signal-to-noise limitations.

### NMR relaxation data measurements {#s4-18-3}

The samples of apo N130 were maintained at a monomer concentration of 215 μM and measurements on solution phase, rpL5-bound N130 contained 190 μM N130 and 475 μM rpL5 (2.5:1 rpL5:N130). R~2~,~α~ and R~2,β~ experiments were performed at three static magnetic fields with Larmor frequencies of 600 (Bruker Avance III), 800 (Bruker Avance I), and 1000 (Bruker Avance III) MHz. This was necessary to have enough independent observables to uniquely determine the parameters that define the relaxation rates. Since N130 consists of a folded pentameric core and disordered N- and C-termini, proper sampling of the relaxation profiles was necessary. Therefore, experiments were recorded with different delay times for resonances from the folded core and the disordered N- and C-termini. For R~2,α/β,~ measurements at 800 and 1000 MHz were subjected to full relaxation delay ([Figure 4b](#fig4){ref-type="fig"},i-ii). All experiments were executed by interleaving the employed delay times. At 600 MHz, R~2,α/β~ rates were measured using a two-point sampling scheme ([@bib34]) at the estimated average value of 1/R~2,α/β~.

Typical acquisition parameters for the R~2,β~ experiment employed 90 and 1024 complex points in the indirect and direct dimension, respectively. For each point, 128 transients were measured and the total experiment time was 32 hr. For R~2,α~, the same number of points in both indirect and direct dimensions were taken, but the number of transients per point was increased to 160. A recycle delay of one second was used for all experiments. Additional R~2,α/β~ experiments were also performed with narrowed sweep widths that focused on the residues from the disordered N- and C-termini with 70 and 1024 complex and 16 transients per point increment. We implemented the R~1~ experiment with TROSY-readout similar to that in Lakomek, *et al.* ([@bib38]), and performed experiments in which 70 and 512 complex points in the indirect and direct dimension, respectively, were acquired with 120 transients per point ([Figure 4b](#fig4){ref-type="fig"},iii). The recycle delay for the R~1~ experiments was set to two seconds yielding a total experiment run time of 38 hr. All sampled delay lengths were interleaved in a random order throughout the experiment.

### Quantification of NMR relaxation rates {#s4-18-4}

All spectra were processed with the NMRPipe package ([@bib16]), visualized with CARA, and analyzed with in-house scripts written in Python using the Scipy computing libraries. Intensity profiles as a function of delay time ([Figure 4b](#fig4){ref-type="fig"},i--iii) were fitted to an exponential decay function in which a single relaxation rate and initial intensity at time zero were extracted. Errors in the measured relaxation rates were determined from Monte-Carlo sampling with 1000 runs where either the base-plane noise or duplicate points were used for the standard deviation in the assumed normal distribution and whose average was placed at the measured intensity value. Errors in R~2,α/β~ data recorded at 600 MHz were propagated from the base-plane noise in each spectrum. From the R~2,α~ and R~2,β~ measurements, η~xy~ values were calculated as half their difference and the error in η~xy~ was determined by error propagation.

A total of 477 (84) individual R~2,α/β~ (R~1~) relaxation rates were quantified for apo N130, and for solution phase, 2.5:1 rpL5:N130, a total of 402 (74) R~2,α/β~ (R~1~) relaxation rates were collected. From the R~2,α/β~ data, a total of 212 and 183 η~xy~ values across all static magnetic fields employed here could be calculated for apo N130 and 2.5:1 rpL5:N130, respectively. We note that the static magnetic field dependence of the absolute value of R~1~ for a protein as large as apo N130 or 2.5:1 rpL5:N130 is small. Although the expected relative difference in R~1~ from 600 to 800 MHz is 32%, and from 800 MHz to 1000 MHz is 22%, the folded core of N130 can be expected to have values between \~0.1 and 0.3 s^-1^. Since the average precision in R~1~ for the free N130 ($R_{1}^{all} = 0.47 \pm 0.07$ s^-1^; $R_{1}^{folded - core} = 0.32 \pm 0.08$ s^-1^) and 2.5:1 rpL5:N130 ($R_{1}^{all} = 0.44 \pm 0.10$ s^-1^; $R_{1}^{folded - core} = 0.28 \pm 0.11$ s^-1^) was 15% and 23% of the average measured rate, respectively, at this level of precision, only R~1~ data at 800 MHz was utilized in the calculations described below. Ultimately, a total of 296 and 257 independent values could be used for further calculation yielding 60% and 51% coverage of the backbone for apo N130 and 2.5:1 rpL5:N130, respectively, yielding approximately four observables per ^15^N nucleus. For the 2.5:1 rpL5:N130 sample, which experiences exchange with peptide in the fast regime, the η~xy~ data represent the population weighted average between the free and the bound states. Regardless, we used the measured η~xy~ values of 2.5:1 rpL5:N130 because N130 was extensively saturated with the rpL5 peptide (93% bound). Bound rates from the population weighted measured rates were calculated, but were found to be within error, and did not deviate from the observed values because of high degree of N130 saturation with the rpL5 peptide.

### Determination of τ~c~ for apo N130 and 2.5:1 rpL5:N130 {#s4-18-5}

η~xy~ and R~1~ are composed of a sum of spectral density functions evaluated at particular frequencies ($\left. J\left( \omega \right) \right)$ which maintain a Lorentzian shape and particular prefactors whose explicit form have been reported previously ([@bib1]; [@bib9]; [@bib53]). In all calculations, ^15^N CSA was set to -162 ppm ([@bib67]), the ^15^N-^1^H^N^ bond length was 1.04 Å ([@bib66]), and the angle between CSA tensor and the unique axis of the N-H bond ([@bib43]) was set to 17°. All other constants that compose the prefactors for η~xy~ and R~1~ were set to their known values ([@bib9]). We utilized the Lipari-Szabo Model-Free formalism ([@bib47]) (LS-MF) to describe the spectral density functions $J\left( \omega \right) = \frac{2}{5}\left( {\frac{S^{2}\tau_{C}}{1 + \left( {\varpi\tau_{C}} \right)^{2}} + \frac{\left( {1 - S^{2}} \right)\tau_{i}}{1 + \left( {\varpi\tau_{i}} \right)^{2}}} \right);\operatorname{}\tau_{i} = \left( {\frac{1}{\tau_{C}} + \frac{1}{\tau_{f}}} \right)$ in which S^2^ and τ~f~ correspond to the ^1^H^N-15^N internuclear vector flexibility (values less than one indicate increased flexibility) and fast picosecond internal motion for a given internuclear vector, respectively ([@bib47]). Using these expressions that describe the relaxation rates of each nucleus, residues were initially subjected to a grid search. This initial search consisted of only residues from the folded core of N130 which were identified based on the crystal structure (PDB: 4N8M). This was done to ensure that they would behave as resonances whose expected ^1^H^N-15^N NOE would be greater than 0.65 following conventional protocols for establishing residues which can be used to determine τ~c~ ([@bib35]). The following method is similar to Lakomek, *et al.* ([@bib39]), and Lorieau, *et al.* ([@bib48]). The grid was evaluated from a range of 0.6 to 1.0 in steps of 0.01 for S^2^ and 0 to 1 ns in steps of 100 ps for τ~f~. τ~c~ was evaluated from 40 to 80 ns in steps of 1 ns. A target function (χ^2^) comprised of the sum of the error weighted squared difference between the experimental and calculated relaxation rates was minimized. All lowest χ^2^ values from each residue's minimization was kept and nuclei with similar τ~c~ values and whose τ~f~ values were either 0 or 100 ps were grouped together and then globally minimized. This global minimization was not conducted in a grid fashion and the minimized parameters included a single τ~c~ and residue specific S^2^ and τ~f~ parameters. The lower limit in τ~c~ was constrained based on the η~xy~ data assuming a rigid rotor spectral density function ([@bib43]) and the error in τ~c~ was determined from Monte-Carlo simulations with all calculations performed in Mathematica (Wolfram Research, Champaign, IL). Rotational anisotropy was not considered under the current analysis; however, the disordered N- and C-termini do fluctuate independently from the folded core based on 1D-TRACT ([@bib43]) data in which two overall correlation times could be extracted (data not shown).

### Determination of binding stoichiometry for 2.5:1 rpL5:N130 {#s4-18-6}

The τ~c~ values discussed above were used as a quantitative assessment of the binding stoichiometry for NPM. $\tau_{c}^{apo\operatorname{}N130}\operatorname{}$and $\tau_{c}^{2.5:1\operatorname{}rpL5:N130}\operatorname{}$were found to be 53.6 ± 0.9 and 67.8 ± 1.1 ns, respectively. $\tau_{c}^{2.5:1\operatorname{}rpL5:N130}\operatorname{}$was 27 ± 4% larger than that of $\tau_{c}^{apo\operatorname{}N130}\operatorname{}$. Since τ~c~ can be a direct reporter in the change of molecular weight (M~r~), we calculated the theoretical τ~c~ value for apo N130 (M~r~ = 73.4 kDa) and 2.5:1 rpL5:N130 using the Stokes-Einstein equation ($\tau_{c,Stokes - Einstein}$) ([@bib9]). For 2.5:1 rpL5:N130, we postulated that for each monomeric unit of the pentamer two peptides would bind, one to A1 and A2, yielding a molecular weight of 95.6 kDa. The mass increase in the 2.5:1 rpL5:N130 complex reflects the change in radius of hydration ($r_{H} = \left( \frac{3\operatorname{}V\operatorname{}M_{r}}{4\pi N_{a}} \right)^{\frac{1}{3}} + r_{w}$) due to peptide binding, in which V, N~a~, and r~w~ are the specific volume of the protein, Avogadro's number, and radius of water (r~w~ = 2 Å), respectively. Formally, $\tau_{c,Stokes - Einstein}^{2.5:1\operatorname{}rpL5:N130}/\tau_{c,Stokes - Einstein}^{apo\operatorname{}N130} = \frac{\left( {2r_{w} + \left( \frac{6}{\pi} \right)^{\frac{1}{3}}\left( \frac{VM_{r,95.6kDa}}{N_{a}} \right)^{\frac{1}{3}}} \right)^{3}}{\left( {2r_{w} + \left( \frac{6}{\pi} \right)^{\frac{1}{3}}\left( \frac{VM_{r,73.4kDa}}{N_{a}} \right)^{\frac{1}{3}}} \right)^{3}}$ and upon evaluation an excellent agreement between the experimentally determined ratio ($\tau_{c}^{2.5:1\operatorname{}rpL5:N130}/\tau_{c}^{apo\operatorname{}N130}$) and the ratio calculated theoretically using the relation above was found. Namely, that $\tau_{c,Stokes - Einstein}^{2.5:1\operatorname{}rpL5:N130}$ is 28% larger than that of $\operatorname{}\tau_{c,Stokes - Einstein}^{apo\operatorname{}N130}$ further confirming a 2:1 (rpL5:N130^monomer^) binding stoichiometry for each monomeric unit within the N130 pentamer. We also further validated the experimentally determined free N130 τ~c~ value using hydrodynamic calculations with the software HYDRONMR ([@bib52]) with structures of N130 that had its N- and C-termini modeled into the structure. The calculated value from HYDRONMR was 56.3 ns and is within 5% of the experimentally determined value.

### Insights into ps to ns motions of the N- and C-termini for apo N130 and 2.5:1 rpL5:N130 {#s4-18-7}

Following determination of global τ~c~ values, local parameters for each residue were evaluated. Either the LS-MF formalism was used or a local MF (local-MF) formalism in which residues were treated completely locally using a single τ~c~ value (τ~c,local~) and S^2^. Local-MF is one in which τ~f~ in LS-MF equals zero. The selection of formalisms was based on fit statistics comparing models with different numbers of parameters with an F-test at 95% confidence interval and on whether minimizations using a particular formalism produced unrealistic values (e.g. S^2^≥1) ([@bib40]). For residues Asp3 to Asp122, the LS-MF formalism was used with the globally determined τ~c~ for the apo and rpL5-bound forms held constant with S^2^ and τ~f~ determined. For residues in the C-terminal A2 tract consisting of Ala123-Glu130, only τ~c,local~ and S^2^ values were determined (local-MF) ([Table 5](#tbl5){ref-type="table"}). Back calculation of all data from the determined parameters yielded an excellent correlation with experimental data. The Pearson correlation coefficient between η~xy~ calculated and observed for all data across all static magnetic fields used here was 0.97 and 0.94 for the apo N130 and 2.5:1 rpL5:N130, respectively. The Pearson correlation coefficient for the R~1~ data collected for apo and rpL5-bound N130 was 0.99 for both datasets. All errors were assessed using Monte-Carlo simulations. This procedure was performed for all data on apo N130 and 2.5:1 rpL5:N130. We note that there was a distinct lack of precision in determining τ~f~ for residues in which LS-MF was used to analyze the data ($\tau_{f}^{N130} = 212 \pm 272\operatorname{}ps,\operatorname{}\tau_{f}^{rpL5:N130} = 272 \pm 310\operatorname{}ps$). This is expected because high frequency motions contribute to a greater extent to R~1~ than to η~xy~ and, with limited R~1~ values only measured at a single magnetic field and for resonances whose R~1~ is larger than the average, error will cause a decrease in precision when determining τ~f~. We note that the average S^2^ for both apo and rpL5-bound forms of N130 are comparable to what is expected for folded proteins([@bib39]) ($S_{apo\operatorname{}N130}^{2} = 0.73 \pm 0.06$ and $S_{2.5:1\operatorname{}rpL5:N130}^{2} = 0.71 \pm 0.10$; average included residues 16--32 and 40--118). Of interest are significant changes to dynamic parameters for residues within the N- and C-termini of N130 due to rpL5 peptide binding ([Figure 4c](#fig4){ref-type="fig"},i--iii).

Although the N- and C-termini remain disordered, the N-terminus exhibits increased rigidity as indicated by the changes in S^2^ values and whose relaxation behavior was best described using the globally determined τ~c~ that was fixed during the LS-MF analysis ([Figure 4c](#fig4){ref-type="fig"},i). Overall, internuclear vector motions were reduced by two-thirds with binding of rpL5 to N130 ($S_{apo\operatorname{}N130}^{2} = 0.16 \pm 0.01$*versus* $\left. S_{2.5:1\operatorname{}rpL5:N130}^{2} = 0.26 \pm 0.02 \right)$. The extraction of parameters that define C-terminal A2 tract motion was not well fit when the overall τ~c~ was fixed, as in the aforementioned analysis. Instead, for the C-terminal A2 tract ([Figure 4c](#fig4){ref-type="fig"},ii-iii), changes in motion were monitored using S^2^ and the overall local correlation time (τ~c,local~). For the A2 tract, this is consistent with slowed local motion and increased rigidity due to peptide binding (green bars; [Figure 4c](#fig4){ref-type="fig"},ii). We note that increased rigidity can be seen beginning from residue Val119. However, we focus on the local-MF analysis for the C-terminal A2 tract (Ala123-Glu130). From [Figure 4c](#fig4){ref-type="fig"},ii, we find that the motion is slowed by a factor two ($\tau_{C}^{apo\operatorname{}N130} = 2.10 \pm 0.05\operatorname{}ns$ and $\tau_{C}^{2.5:1\operatorname{}rpL5:N130} = 4.56 \pm 0.06\operatorname{}ns$) for the C-terminal residues and flexibility ([Figure 4c](#fig4){ref-type="fig"},iii) is reduced by nearly half ($S_{apo\operatorname{}N130}^{2} = 0.44 \pm 0.01$ and $S_{2.51\operatorname{}rpL5:N130}^{2} = 0.76 \pm 0.01$). We also note that residues at the beginning of the A2 tract (Val119-Asp122), which were well fit when τ~c~ was fixed to the overall tumbling value, also exhibited restricted motion in the 2.5:1 rpL5:N130 state (by about 30%) as compared with apo N130. τ~c,local~ for Ser125 in N130 could not be determined because the resonance was overlapped in the apo state.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

\[Editors' note: a previous version of this study was rejected after peer review, but the authors submitted for reconsideration. The first decision letter after peer review is shown below.\]

Thank you for choosing to send your work entitled \"NPM1 facilitates nucleolar assembly through phase separation with ribosomal components\" for consideration at *eLife*. Your full submission has been evaluated by John Kuriyan (Senior editor) and three peer reviewers, one of whom served as a guest member of our Board of Reviewing Editors (Michael Rosen), and the decision was reached after discussions between the reviewers. Based on our discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in *eLife*.

This manuscript reports on the in vitro properties of NPM1, an abundant nucleolar protein with many cellular functions. The authors use a suite of techniques, including fluorescence anisotropy, small angle neutron scattering, NMR spectroscopy, and FRAP to understand the molecular driving forces for assembly of the nucleolus. They find that the oligomerization domain of NPM1 can phase separate in the presence of peptides containing two R-rich motifs commonly found in NPM1 binding partners, including the ribosomal protein rpL5. They also demonstrate that full length NPM1 can phase separate with ribosomal RNA and the R motif-containing rpL5 peptide and uncover distinct roles for the oligomerization and nucleic acid-binding domains of NPM1 in droplet formation and morphology. Using NMR they show that the internal dynamics of NPM1 greatly slow within the phase separated droplets.

The referees all feel that these data are interesting, and provide new information regarding the mechanisms of protein phase separation. However, the in vitro data on NPM1 do not in themselves provide sufficient conceptual advance for publication in *eLife*. Such an advance would require strong connections to the cellular properties and behaviors of nucleoli, and here the paper falls short.

The authors wish to conclude from the data presented that \"NPM1 facilitates nucleolar assembly through phase separation with ribosomal components\" (title of paper). However there are no in vivo experiments to support this conclusion. This would require experiments that compare the effect of NPM1 mutants on droplet formation in vitro and nucleolar biogenesis in vivo, to demonstrate that the in vitro assay used here is relevant to nucleolar biogenesis.

In the last experiment of the paper, the author show that GFP:NPM1 accumulates in purified nucleoli and that NPM1 droplets formed in vitro associate with purified nucleoli. The authors offer these observations as evidence for in vivo relevance. However the pictures shown in [Figure 12](#fig12){ref-type="fig"} indicate that the NPM1 droplets dock but do not fuse with the nucleoli, which does not support the authors assertion of \"compatibility\". Further, the specificity of the data in [figure 12](#fig12){ref-type="fig"} is not addressed. Using only DIC imaging to monitor the isolated nucleoli, it is unclear if the nucleoli are dissolving in the droplets or simply being surrounded by them. If the latter, is this behavior specific to nucleoli, or would the droplets adhere to and engulf any object they settled on? Without additional data linking the in vitro observations to an in vivo phenomenon, the main thesis of the paper (that NPM1 phase separation properties drive nucleolar biogenesis) is not supported.

Additional detailed comments on the manuscript and work are provided below.

1\) The concentrations needed for phase separation are quite high. This raises questions about the contribution of Npm1 phase separation to nucleoli. However, this concern could be alleviated by further, quantitative studies of cooperativity between RNA and rpL5, akin to those in [Figure 1](#fig1){ref-type="fig"}. Cooperativity could drop phase separation into a more physiologic concentration range.

2\) In general, for analytical measurements made above the phase separation concentration, the authors have not addressed how the heterogeneity of the solution will impact the data or interpretations thereof. This is an issue in the NMR data of [Figure 5](#fig5){ref-type="fig"} and also the fluorescence anisotropy data of [Figure 3a](#fig3){ref-type="fig"}.

2A) As far as I can tell, the NMR analyses of \"the droplet state\" were carried out on a mixture of droplet + bulk, rather than pure droplet state. Thus, the NMR behaviors reflect a complex average of the two states of the system, which will depend on the relative amounts of the two states (which is not provided) and their properties. While the qualitative features of the droplet state are likely correct (dynamics are slowed), this mixing calls into question the quantitative aspects of the analysis. The authors need to address this issue in their analyses and presentation of the work.

The fact that the relaxation data for the N- and C-termini could be fit globally does not in itself indicate that these elements undergo collective motions, as is stated in the text. If one assumes collective motion, then the global fitting can give greater precision in the derived values. But the interpretation does not go in the other direction in the absence of knowing what the errors should be if the motions were not collective. Phrased differently, what would the authors have observed in their analyses if the motions had been uncoupled but were fit as collective? Would the fitting have produced qualitatively different results? Or would the errors in the fitted parameters have simply been larger? If only the latter, at what point does one say the hypothesis of collective motion was wrong? Statistical analyses are needed to support this assertion.

2B) The fluorescence anisotropy experiments of [Figure 3a](#fig3){ref-type="fig"} will be complicated by light scattering by the droplets. The experiments are not described in sufficient detail to assess whether and how scattering was dealt with. Without this, it is hard to know how to interpret the break in the curve at \~x=2.5. Is this just the onset of scattering by the phase transition? Or does it represent a different tumbling rate of the molecules in the droplet phase?

3\) The requirement for multivalency is not well-tested by the rpL5-RA peptide, as its affinity for N130 is appreciably lower than the other proteins examined. Thus, it is not clear whether the lack of phase separation results from the charged residues being clustered into a single block, or from the lower affinity. The data on the N122 protein make a stronger case (as does a comparison of the various R-motif proteins, where higher valency seems to correlate with a lower phase separation concentration). But the authors should seek a higher affinity mono-valent peptide in the first experiments.

4\) The authors should also analyze their 2:1 SANS data in [Figure 3](#fig3){ref-type="fig"}, to see if higher-order species (beyond the assemblies seen a 1:1) begin to appear before phase separation occurs.

5\) The molecular pictures shown in [Figure 7b](#fig7){ref-type="fig"} do not accurately reflect the authors\' model. Comparing the 2:1 and 3:1 stoichiometries, it appears as though the fractional saturation of the A tracts decreases as more rpL5 is added. This cannot be the case. It is also not clear from the authors\' description in paragraph four, Results, exactly what causes phase separation when the rpL5 concentration reaches the critical value. The authors describe the appearance of interpentamer crosslinks as occurring suddenly when rpL5 reaches some concentration and driving phase separation. But there should always be some such crosslinks. Affinity aside, one might expect that crosslinks would be most favored at low rpL5 stoichiometries. Maybe the key issue is solubility of the various species?

6\) The data in [Figure 11b](#fig11){ref-type="fig"} are confusing, at least as described. What does the y-axis represent? \"Fold-increase\" over what fluorescence? The bulk (non-nucleolar) fluorescence at each point, or some initial fluorescence? If the former, so that each point represents the fold-increase of nucleolar fluorescence over background (bulk solution) fluorescence, then the data do not show saturation. Rather, in this case a constant fold-increase as the total gN294 rises means that the nucleolar fluorescence rises linearly. For a saturating system, the ratio of nucleolar/bulk fluorescence should decrease above the saturation point as the denominator grows and the numerator remains constant. If the y-axis is relative to some initial fluorescence value, the system does show saturation, but it is not clear what that initial point is.

7\) I believe the squares and circles in [Figure 4a](#fig4){ref-type="fig"} should be reversed. The resonance in the core, currently indicated with the squares, should have faster transverse relaxation than those in the disordered A2 tract, currently indicated with the circles. But the opposite is observed in the data. The legend of [Figure 4a](#fig4){ref-type="fig"} should state more clearly what is shown in each panel. \"Decay curve\" doesn\'t say what the axes are.

8\) In [Figure 6](#fig6){ref-type="fig"}, most of the change in FRET occurs upon binding rpL5 (e.g. in the 2.7:1 mixture in panel b), in the absence of phase separation. So the change is not dependent on phase separation, but rather rpL5 binding. This should be described differently in paragraph four, Results.

9\) In the beginning of the Discussion, the authors should be more cautious in describing the physical nature of the droplets. Their model posits a \"mesh-like lattice\", but this is only indirectly supported by their data. In paragraph two, the authors should also be more cautious. It seems unlikely that NPM1 participates in every single chemical transaction that occurs within the GC.

10\) There is a statement: \"Thus, multivalent R-motifs are a hallmark of NPM1-bound nucleolar proteins\". However, I think an enrichment from 44% of all human proteins to 73% of NPM-1binding proteins does not support the use of the word \"Hallmark\".

11\) Paragraph three, Results: Explain FA technique briefly.

12\) The discussion in the Results moves very quickly. It will be difficult for non-structural biologists (and probably even for structural biologists), such as would be the typical *eLife* reader, to follow. I suggest simplifying and using better transitions, highlighting the \"take-home message\" at each step etc.

13\) In paragraph four, Results, it says that the second transition in the FA curve corresponds to phase separation. But this data seems to be taken at 200 µM N130. Looking at the phase diagrams in [Figure 1](#fig1){ref-type="fig"}, this is higher than all shown concentrations. How is the claim about the FA transition reflecting phase separation possible, since these concentrations do not appear to support phase separation?

14\) I was confused by the statement in paragraph five, Results, that \"the morphology of droplets\" was strongly influenced by their composition. If they are liquids droplets in suspension, shouldn\'t they basically always have a spherical morphology? If they are true liquids but have some elongated shapes, it presumably reflects interactions with the surface (wetting) -- this seems to be the case in the images in [Figure 10](#fig10){ref-type="fig"}. So is the statement about droplet morphology really about surface wetting behavior that may depend on composition?

15\) [Figure 10](#fig10){ref-type="fig"} -- the title reads \"...and accumulation in isolated nucleoli\". But if I understand correctly there are no isolated nucleoli in this figure.

16\) There are many abbreviations throughout the paper that make reading difficult.

10.7554/eLife.13571.042

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

We regret that certain speculative aspects of the manuscript, which in retrospect should have been presented differently, were viewed as few major weaknesses by the three reviewers. We have revised the manuscript to avoid excessive speculation and to present the major conclusions more clearly. Furthermore, a weakness as regards biological relevance has been addressed through new cellular experiments and a novel bioinformatics analysis. These and additional new in vitro data have allowed us to address all of the reviewers' concerns. With these improvements, we feel that our manuscript offers a significant conceptual advance in understanding the molecular mechanism of protein localization within the liquid-like matrix of the nucleolus.

The main points of the revised manuscript are as follows:

-   A principal goal was to understand the molecular mechanism of integration of NPM1 within the nucleolar matrix.

-   We identify, through in vitro experiments, two types of multivalent features of NPM1 (oligomeric acidic tracts and nucleic acid binding domains) that mediate phase separation with two types of nucleolar components: i) proteins that display multivalent, arginine-rich short linear motifs (R-motifs) and ii) ribosomal RNA (rRNA).

-   Importantly, the acidic low complexity regions, as well as the oligomerization-mediated multivalency are two novel classes of structural features associated with protein-protein and protein-RNA phase separation.

-   Cellular experiments showed that both types of multivalent features are required for integration of NPM1 within the nucleolar matrix.

-   These in vitro and cellular results suggest strongly that the ability of NPM1 to phase separate in vitro with nucleolar components is associated with its ability to integrate within the nucleolar matrix.

-   The sequence features of proteins shown to cause phase separation with NPM1 in vitro match those of canonical nucleolar localization signals shown by others to mediate the nucleolar localization of hundreds of proteins.

-   Therefore, we propose that the localization of a large proportion of nucleolar proteins is mediated by their ability to phase separate within the nucleolar matrix due to the three types of multivalent features identified in this study.

*\[...\] The referees all feel that these data are interesting, and provide new information regarding the mechanisms of protein phase separation. However, the in vitro data on NPM1 do not in themselves provide sufficient conceptual advance for publication in eLife. Such an advance would require strong connections to the cellular properties and behaviors of nucleoli, and here the paper falls short.*

In order to strengthen biological relevance and to emphasize a key conceptual advance, we re-focused the manuscript towards the identification of a currently unknown molecular mechanism responsible for protein targeting to nucleoli. To validate our in vitro findings, which show that both the ability to oligomerize and to bind nucleic acids is required for NPM1 to phase separate with ribosomal RNA and a multivalent R-motif-containing peptide, we created cell lines that stably express mCherry-NPM1 constructs that parallel those used in the in vitro studies. We show by fluorescence microscopy that only the full length protein can accumulate within mammalian nucleoli and co-localize with known nucleolar markers ([Figure 12](#fig12){ref-type="fig"} and [Figure 12---figure supplement 1](#fig12s1){ref-type="fig"}). The major conceptual advance is that the protein sequence features (multivalent R-motifs) we have identified as being required for binding to and phase separation with NPM1 correspond to features identified by others as being nucleolar localization signals (NoLSs). We gained this insight by using bioinformatics tools to compare our list of NPM1 binding proteins with another from others of NoLSs in all human nucleolar proteins; we present this analysis in the Discussion of the revised manuscript. Thus, we propose that the molecular mechanism of protein phase separation with NPM1 that we describe is, in essence, the mechanism through which hundreds of proteins are localized within the nucleolus.

*The authors wish to conclude from the data presented that \"NPM1 facilitates nucleolar assembly through phase separation with ribosomal components\" (title of paper). However there are no in vivo experiments to support this conclusion. This would require experiments that compare the effect of NPM1 mutants on droplet formation in vitro and nucleolar biogenesis in vivo, to demonstrate that the in vitro assay used here is relevant to nucleolar biogenesis.*

We replaced the speculative title, "NPM1 facilitates nucleolar assembly through phase separation with ribosomal components," with one that better reflects the specific findings of our study. The title now reads, "NPM1 integrates within the nucleolus via multi-modal interactions with proteins displaying R-rich linear motifs and rRNA".

*In the last experiment of the paper, the author show that GFP:NPM1 accumulates in purified nucleoli and that NPM1 droplets formed in vitro associate with purified nucleoli. The authors offer these observations as evidence for in vivo relevance. However the pictures shown in [Figure 12](#fig12){ref-type="fig"} indicate that the NPM1 droplets dock but do not fuse with the nucleoli, which does not support the authors assertion of \"compatibility\". Further, the specificity of the data in [figure 12](#fig12){ref-type="fig"} is not addressed. Using only DIC imaging to monitor the isolated nucleoli, it is unclear if the nucleoli are dissolving in the droplets or simply being surrounded by them. If the latter, is this behavior specific to nucleoli, or would the droplets adhere to and engulf any object they settled on? Without additional data linking the in vitro observations to an in vivo phenomenon, the main thesis of the paper (that NPM1 phase separation properties drive nucleolar biogenesis) is not supported.*

We agree with the reviewers that the conclusions from the "compatibility" experiments were speculative and therefore completely eliminated these data (original [Figure 12](#fig12){ref-type="fig"}) and the associated text from the revised manuscript. Rather, a more direct connection to in vivo relevance was added in the revised version of the manuscript in the form of cellular experiments, as discussed above.

*Additional detailed comments on the manuscript and work are provided below. 1) The concentrations needed for phase separation are quite high. This raises questions about the contribution of Npm1 phase separation to nucleoli. However, this concern could be alleviated by further, quantitative studies of cooperativity between RNA and rpL5, akin to those in [Figure 1](#fig1){ref-type="fig"}. Cooperativity could drop phase separation into a more physiologic concentration range.*

We agree with the reviewers that the concentration required for phase separation of N130 with the peptide is quite high. However, the critical concentration for the system drops \~5-fold when N130 is replaced with full length NPM1 (N294). This point is discussed in the current manuscript: "Furthermore, droplets of NPM1 with rpL5 formed at \~5-fold lower concentrations of both components ([Figure 8b](#fig8){ref-type="fig"}) than were required for phase separation with N130 and rpL5 ([Figure 1b](#fig1){ref-type="fig"}) due to the higher valency of acidic tracts within the full-length protein." The data presented in [Figure 8a-b](#fig8){ref-type="fig"} and [Figure 11](#fig11){ref-type="fig"} show that phase separation occurs in the tens of micromolar concentration regime with the divalent peptide, with ribosomal RNA and with both; we argue that this concentration regime is physiologically relevant.

*2) In general, for analytical measurements made above the phase separation concentration, the authors have not addressed how the heterogeneity of the solution will impact the data or interpretations thereof. This is an issue in the NMR data of [Figure 5](#fig5){ref-type="fig"} and also the fluorescence anisotropy data of [Figure 3a](#fig3){ref-type="fig"}. 2A) As far as I can tell, the NMR analyses of \"the droplet state\" were carried out on a mixture of droplet + bulk, rather than pure droplet state. Thus, the NMR behaviors reflect a complex average of the two states of the system, which will depend on the relative amounts of the two states (which is not provided) and their properties. While the qualitative features of the droplet state are likely correct (dynamics are slowed), this mixing calls into question the quantitative aspects of the analysis. The authors need to address this issue in their analyses and presentation of the work. The fact that the relaxation data for the N- and C-termini could be fit globally does not in itself indicate that these elements undergo collective motions, as is stated in the text. If one assumes collective motion, then the global fitting can give greater precision in the derived values. But the interpretation does not go in the other direction in the absence of knowing what the errors should be if the motions were not collective. Phrased differently, what would the authors have observed in their analyses if the motions had been uncoupled but were fit as collective? Would the fitting have produced qualitatively different results? Or would the errors in the fitted parameters have simply been larger? If only the latter, at what point does one say the hypothesis of collective motion was wrong? Statistical analyses are needed to support this assertion.*

We agree with the reviewers that we over-interpreted the NMR relaxation data for \"the droplet state\". In response to the reviewers' comment, we performed new sedimentation velocity analytical ultracentrifugation experiments ([Table 3](#tbl3){ref-type="table"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}), which showed, indeed, that small N130 pentamer/rpL5 assemblies exist in equilibrium with the microscopically-detected droplets under conditions of phase separation. Therefore, we agree that we cannot interpret the NMR relaxation data for the droplet state as we did, and have eliminated these data from the manuscript. We do still briefly discuss the qualitative features of the 2D TROSY spectrum obtained under these conditions. Also, we still include the NMR relaxation analyses of N130 at N130:rpL5 stoichiometries below the threshold for phase separation, as follows:

"Above the phase separation threshold (\>3:1 rpL5:N130), resonances for residues within the N130 core broadened beyond detection in 2D 1H-15N TROSY spectra but not those for residues within the A2 tract ([Figure 4a](#fig4){ref-type="fig"}). Chemical shift values indicated that these residues remained disordered."

*2B) The fluorescence anisotropy experiments of [Figure 3a](#fig3){ref-type="fig"} will be complicated by light scattering by the droplets. The experiments are not described in sufficient detail to assess whether and how scattering was dealt with. Without this, it is hard to know how to interpret the break in the curve at \~x=2.5. Is this just the onset of scattering by the phase transition? Or does it represent a different tumbling rate of the molecules in the droplet phase?*

This is a valid point raised by the reviewers. For the fluorescence anisotropy experiments, we used Alexa594 fluorophore labeled Npm-130^S125C^ (1 μM), mixed with unlabeled N130 (199 μM), with λ~ex~ = 580 nm, and λ~ex~ = 618 nm. Under these conditions, the light scattering contribution towards the fluorescence intensity due to liquid-liquid phase separation is \< 5%, as measured using identical solution conditions lacking the labeled protein. Therefore, the 2nd transition in the anisotropy curve must represent the liquid-liquid phase separation with an altered tumbling rate of the N130 in the droplets, compared to the single-phase region in the phase diagram.

*3) The requirement for multivalency is not well-tested by the rpL5-RA peptide, as its affinity for N130 is appreciably lower than the other proteins examined. Thus, it is not clear whether the lack of phase separation results from the charged residues being clustered into a single block, or from the lower affinity. The data on the N122 protein make a stronger case (as does a comparison of the various R-motif proteins, where higher valency seems to correlate with a lower phase separation concentration). But the authors should seek a higher affinity mono-valent peptide in the first experiments.*

We rephrased the sentence to acknowledge the decrease in binding affinity:

"At the same N130 concentration, phase separation was not observed upon titration of a monovalent R-motif peptide (rpL5-RA; [Figure 2b](#fig2){ref-type="fig"}), even though it bound, albeit with lower affinity ([Table 2](#tbl2){ref-type="table"} and [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), confirming that R-motif multivalency is required for phase separation with N130."

Furthermore, in order to test the alternative explanation for the results proposed by the reviewer, namely that the lack of phase separation is caused by the weaker binding affinity, we performed light scattering assays of N130 titrations with a poly arginine peptide (RRRRRR), which has a similar binding affinity for the folded pentameric core of NPM1 as the divalent rpL5 peptide. In support of our model, this tighter binding, but monovalent, peptide did not phase separate with N130. The new data are presented in [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"} and the following phrase has been added to the Results section:

"The inability to phase separate was not due to reduced binding affinity (rather than loss of multivalency); a poly-R peptide, containing a single but longer R-motif, with affinity similar to that of rpL5, also failed to phase separate ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"})."

*4) The authors should also analyze their 2:1 SANS data in [Figure 3](#fig3){ref-type="fig"}, to see if higher-order species (beyond the assemblies seen a 1:1) begin to appear before phase separation occurs.*

The analysis of the 2:1 SANS data is presented in the Analysis Methods section, in the subheading "SANS data analysis". Additionally, we performed sedimentation velocity analytical ultracentrifugation assays to analyze the molecular weight distribution of the species present in the 0:1, 1:1, 2:1 and 3:1 rpL5:N130 samples ([Table 3](#tbl3){ref-type="table"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). These additional results confirm the formation of higher order complexes at the 2:1 rpL5:N130 molar ratio, below the critical concentration at which microscopic droplets can be observed. We included a discussion of these results:

"Notably, nascent, higher order structural organization was evident in the SANS curve for a solution of rpL5 and N130 with 2:1 stoichiometry ([Figure 3b](#fig3){ref-type="fig"}, green curve). \[...\] The appearance of high molecular weight species within the detection range (\< 1 MDa) was accompanied by a progressive decrease in the total mass detected, likely due to sedimentation of rpL5:N130 droplets in the sample cell during the dead-time of the experiment."

*5) The molecular pictures shown in [Figure 7b](#fig7){ref-type="fig"} do not accurately reflect the authors\' model. Comparing the 2:1 and 3:1 stoichiometries, it appears as though the fractional saturation of the A tracts decreases as more rpL5 is added. This cannot be the case. It is also not clear from the authors\' description in paragraph four, Results, exactly what causes phase separation when the rpL5 concentration reaches the critical value. The authors describe the appearance of interpentamer crosslinks as occurring suddenly when rpL5 reaches some concentration and driving phase separation. But there should always be some such crosslinks. Affinity aside, one might expect that crosslinks would be most favored at low rpL5 stoichiometries. Maybe the key issue is solubility of the various species?*

We thank the reviewers for pointing out this source of confusion. We now explicitly state in the figure legend ([Figure 6](#fig6){ref-type="fig"} in the revised manuscript) that "only a subset of the possible inter-N130 pentamer crosslinks are shown for clarity." Additionally, we revised the text to better explain our model:

"As rpL5 is titrated into N130 up to 2:1 stoichiometry (rpL5:N130), the R1 motifs, comprised of four Arg residues each, bind to acidic residues within the A1 binding groove and disordered A2 tract of N130, with the R2 motif available for interactions. \[...\]Together, our data support the hypothesis that the molecular basis of phase separation is the formation of non-covalent, inter-N130 pentamer interactions via the two R-motifs within the same rpL5 peptide molecule."

*6) The data in [Figure 11b](#fig11){ref-type="fig"} are confusing, at least as described. What does the y-axis represent? \"Fold-increase\" over what fluorescence? The bulk (non-nucleolar) fluorescence at each point, or some initial fluorescence? If the former, so that each point represents the fold-increase of nucleolar fluorescence over background (bulk solution) fluorescence, then the data do not show saturation. Rather, in this case a constant fold-increase as the total gN294 rises means that the nucleolar fluorescence rises linearly. For a saturating system, the ratio of nucleolar/bulk fluorescence should decrease above the saturation point as the denominator grows and the numerator remains constant. If the y-axis is relative to some initial fluorescence value, the system does show saturation, but it is not clear what that initial point is.*

We replaced the Y axis labeling from "Fold-increase"to "I/I~background~ "in [Figure 11b](#fig11){ref-type="fig"} ([Figure 12b and c](#fig12){ref-type="fig"} in the revised manuscript) for clarity and modified the language in the legend correspondingly. As the reviewers correctly stated, the ratio of nucleolar vs. bulk fluorescence does decrease from \~ 25 at 20 μM eGFP-N294 to \~ 15 for 100 μM eGFP-N294 (compare [Figure 12b](#fig12){ref-type="fig"} with 12c), consistent with a model where the eGFP-N294 accumulation within isolated nucleoli is a saturable process. However, since we are not drawing any mechanistic conclusions based on this observation, we decided to not mention the saturation phenomenon in the revised manuscript.

*7) I believe the squares and circles in [Figure 4a](#fig4){ref-type="fig"} should be reversed. The resonance in the core, currently indicated with the squares, should have faster transverse relaxation than those in the disordered A2 tract, currently indicated with the circles. But the opposite is observed in the data. The legend of [Figure 4a](#fig4){ref-type="fig"} should state more clearly what is shown in each panel. \"Decay curve\" doesn\'t say what the axes are.*

We thank the reviewers for carefully examining the manuscript and pointing out this error. We corrected the erroneous legend. The [Figure 4](#fig4){ref-type="fig"} legend now reads: "Circles and squares indicate data points for residues Tyr29 (within in the folded pentamer core) and Glu121 (within the disordered A2 tract), respectively."

Additionally, we clarified the language in the legend for [Figure 4b](#fig4){ref-type="fig"}, by specifying what the Y axis represents, as follows: "Examples of R~2,b~ and R~2,a~ peak intensity decay curves measured at 800 MHz (i) and 1000 MHz (ii), and R1 peak intensity decay curves measured at 800 MHz (iii) for free N130."

8\) In [Figure 6](#fig6){ref-type="fig"}, most of the change in FRET occurs upon binding rpL5 (e.g. in the 2.7:1 mixture in panel b), in the absence of phase separation. So the change is not dependent on phase separation, but rather rpL5 binding. This should be described differently in paragraph four, Results.

In smFRET measurements, the histograms reveal the identity of individual species in a heterogeneous mixture. In the single-phase solution, the native N130 pentamer is characterized by a single E~FRET~ peak \~ 0.85. When titrated against increasing \[rpL5\], there was no notable change in the histograms at a mole fraction of rpL5 (1:1 and 1:2) where binary complexes of N130 and the peptide were formed (as detected by FA, AUC and SANS), suggesting that the conformational features of N130 reported on by FRET were not altered significantly due to binding of the peptide in the single phase region of the phase diagram.

Droplet formation of N130 was initiated \~ 2.5 mole fraction (rpL5:N130). Therefore, at 2.7 mole fraction, we are measuring the conformational changes of N130 due to droplet formation or formation of higher order complexes, as indicated by AUC analysis, which was signaled by a relatively lower E~FRET~ peak. Under this condition, no liquid-like microscopic droplets can be observed. We also observe the native smFRET peak for N130 as well, which signifies the coexistence of both these states under this condition. The smFRET data \> 3.0 mole fraction is essentially the same as the 2.7 mole fraction data, except that the native peak is significantly smaller, and total number of events are lower which may be due to less frequent diffusion of the larger droplets through the confocal volume. Also, sedimentation of the droplets can exclude the higher density phase from the detection volume, playing a role in lowering the number of events observed under this condition.

*9) In the beginning of the Discussion, the authors should be more cautious in describing the physical nature of the droplets. Their model posits a \"mesh-like lattice\", but this is only indirectly supported by their data. In paragraph two, the authors should also be more cautious. It seems unlikely that NPM1 participates in every single chemical transaction that occurs within the GC.*

We regret any confusion caused by use of the term \"mesh-like lattice\" in the original manuscript. We now avoid this term. Importantly, we provide additional evidence to support our model for the structural organization of N130/rpL5 liquid-like droplets. Specifically, we performed SANS experiments with droplets formed by N130 with a variant rpL5 peptide in which the linker between the two R-motifs was duplicated (rpL5-2xLinker; see [Table 1](#tbl1){ref-type="table"}). The results, shown in [Figure 7](#fig7){ref-type="fig"}, show that the longer peptide causes the correlation distances to become larger and to broaden. This suggests strongly that the rpL5 peptides, either wild-type or the 2xLinker variant, influence the inter-molecular spacing of N130 molecules within the liquid-like phase. We discuss these results in the revised manuscript, as follows.

"We propose that these rpL5-mediated interactions establish the inter-pentamer spacing within the droplet phase that was detected by SANS ([Figure 3b](#fig3){ref-type="fig"}). \[...\] We envision that such cross-links are dynamically formed and broken but that, once phase separation occurs, they dominate the structural organization detected by SANS."

In addition, to elaborate on the "structural organization" of the N130/rpL5 liquid-like phase, we have added a new paragraph in the Discussion, as follows:

"In our structural studies of the minimal phase separating system, N130/rpL5, we showed that within the liquid-like matrix of the droplets, with diameters on the microns to tens of microns length scale, we observed local ordering on the length scale of 5 to 12 nanometers ([Figure 3](#fig3){ref-type="fig"} and [Figure 7](#fig7){ref-type="fig"}). \[...\] This model for thestructurally heterogenous integration of NPM1 within the nucleolar matrix heterogenous provides a mechanistic explanation for its central role into many nucleolar functions, such as ribosome biogenesis and nucleolar stress responses (Lindstrom, 2011)."

We hope that this clarifies our view of "structural organization" within the N130/rpL5 droplets and the relevance of this model to the much more complex and heterogeneous GC region of the nucleolus.

*10) There is a statement: \"Thus, multivalent R-motifs are a hallmark of NPM1-bound nucleolar proteins\". However, I think an enrichment from 44% of all human proteins to 73% of NPM-1binding proteins does not support the use of the word \"Hallmark\".*

We changed the language and eliminated the word "hallmark". The sentence now reads: "Thus, multivalent R-motifs are enriched in proteins that bind to NPM1."

*11) Paragraph three, Results: Explain FA technique briefly*.

Please see our response to point 8, above.

*12) The discussion in the Results moves very quickly. It will be difficult for non-structural biologists (and probably even for structural biologists), such as would be the typical eLife reader, to follow. I suggest simplifying and using better transitions, highlighting the \"take-home message\" at each step etc.*

Please see our response to point 16.

*13) In paragraph four, Results, it says that the second transition in the FA curve corresponds to phase separation. But this data seems to be taken at 200 µMN130. Looking at the phase diagrams in [Figure 1](#fig1){ref-type="fig"}, this is higher than all shown concentrations. How is the claim about the FA transition reflecting phase separation possible, since these concentrations do not appear to support phase separation?*

The phase diagrams in [Figure 1b](#fig1){ref-type="fig"} represent a sub-set of N130 concentrations at which phase separation was observed with all four multivalent R-motif containing peptides. rpL5 has the lowest valency of them all, and therefore has the highest concentration threshold for phase separation. Titrations of 200 μM N130 with rpL5 peptide and the phase separation threshold for this particular binary system are further described in [Figure 2](#fig2){ref-type="fig"}. We included the following statement, justifying the use of the 200 μM N130 concentration:

"At 200 μM N130, upon titration of the divalent rpL5 peptide, phase separation was observed when the rpL5:N130 ratio reached \~3:1 ([Figure 2b](#fig2){ref-type="fig"})."

*14) I was confused by the statement in paragraph five, Results, that \"the morphology of droplets\" was strongly influenced by their composition. If they are liquids droplets in suspension, shouldn\'t they basically always have a spherical morphology? If they are true liquids but have some elongated shapes, it presumably reflects interactions with the surface (wetting)* -- *this seems to be the case in the images in [Figure 10](#fig10){ref-type="fig"}. So is the statement about droplet morphology really about surface wetting behavior that may depend on composition?*

The language in the new manuscript has been extensively revised. Furthermore, we reproduced the results using silane-coated slides, to avoid excessive interactions of the droplets with the surface. The slide treatment minimized artifacts arising from "wetting" effects for most of the conditions examined. We thus eliminated the "morphology of droplets" terminology from the revised manuscript and refer specifically to the size of the droplets as a parameter that varies between different types of droplets.

*15) [Figure 10](#fig10){ref-type="fig"}* -- *the title reads \"*...*and accumulation in isolated nucleoli\". But if I understand correctly there are no isolated nucleoli in this figure.*

The figures have been extensively modified, so this point is no longer applicable in the revised manuscript.

16\) There are many abbreviations throughout the paper that make reading difficult.

The language in the manuscript has been extensively revised to improve the flow and make reading less tedious. Additionally, we included a schematic representation of the different NPM1 constructs used in the revised manuscript in [Figure 2a](#fig2){ref-type="fig"}.

[^1]: Cancer Center, University of Louisville, Louisville, United States.

[^2]: ^\#^The peptides are referred to by the same name as the protein they originate from and the residue numbers of their N- and C-termini are indicated.

[^3]: ^\*^ Not determined due to multiple, unresolved binding events.

[^4]: ^\#^ Heat change was too weak for accurate data analysis.

[^5]: Average values from a minimum of three independent experiments are reported ± SD.

[^6]: *^a^* Total concentration in mg/ml.

[^7]: *^b^* Sedimentation coefficient taken from the ordinate maximum of each peak in the best-fit *c(s)* distribution at 20 °C with percentage protein amount in parenthesis. Sedimentation coefficient (*s*-value) is a measure of the size and shape of a protein in a solution with a specific density and viscosity at a specific temperature.

[^8]: *^c^* Standard sedimentation coefficient (*s~20,w~*-value) in water at 20 °C.

[^9]: *^d^* Molar mass values (MW) taken from the *c(s)* distribution that was transformed to the *c(M)* distribution. The theoretical molar mass is in parenthesis.

[^10]: *^e^*Best-fit weight-average frictional ratio values *(f/f~0~)*~w~ taken from the *c(s)* distribution.

[^11]: ^f^ Fit of the data in the 100-300 min sedimentation time frame, for the analysis of the lower MW rpL5:N130 complex intermediates. The MW cutoff of \~ 300 kDa corresponds to a tetramer of N130 pentamers.

[^12]: ^a^Dynamic parameters for the N-terminus were determined using a global $\tau_{c}$ value; thus, the only residue-specific motional parameter for residues within the N-terminus was $S_{f}^{2}$ (see Materials and Methods).
